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Abstract 
The first embryonic stem ES cell line was isolated from mouse in 1981 (Evans 
and Kaufman 1981; Martin1981). However, ESCs are only available in rodent 
species. Although research has been carried out on bovine embryos for more 
than two decades, there is no evidence of ESCs (Shanbo, Fang et al. 2009). 
Reasons for this are unknown developmental aspects associated with bovine 
embryology.  
Most attempts to culture bovine ES-like cells have been to isolate them from 
the ICM of day seven blastocysts, which have been generated by in vitro 
production (IVP). Here I report an alternative method to derive bES-like cells 
using dissociated blastomeres from early stages embryos (8 and 16-cell) and 
day 5 and 7 embryos. These bovine outgrowths were cultured in order to 
investigate which developmental stage associated with better blastomere 
attachment. Also, to examine their pluripotency, as it was hypothesised that 
early stages of development up to the blastocyst stage are pluripotent and that 
the naive state of bovine ESCs exist. In addition, instead of using animal 
material as feeder layers such as mouse embryonic fibroblasts (MEFs), which 
provides leukemic inhibitory factor (LIF) to maintain pluripotency, defined 
extra cellular matrixes (ECM) were used in order to derive bES-like cells in 
defined conditions, avoid contamination by reagents used in cell culture and to 
find the substrate associated with better attachment and proliferation.    
 2i media was applied to the development of bovine embryos in order to 
determine if the use of 2i media with different numbers of blastomeres would 
encourage bES-like cell development, proliferation and to introduce cell 
uniformity. Blastomeres were cultured singularly, and in groups in 96 well 
plates and in tissue culture plates in order to produce short term cell lines. 
Development rate, attachment and outgrowth production were measured, for 
example, the proportion of blastomeres attached and proliferated. Markers of 
ESCs, epiblast stem cells (epiESCs) and trophectoderm were investigated in 
produced bovine outgrowths in order to examine their pluripotency, and their 
karyotyping was examined. 
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In this study, from the different developmental stages used, outgrowths were 
produced from all stages used, but the inner cell mass (ICM) was associated 
with better outgrowth production. Different ECMs promoted attachment, 
however, with variable efficiency, in which gelatin was associated with better 
attachment and proliferation. The use of 2i media resulted in attachment, but 
with poor proliferation. cDNA isolated from bovine outgrowths expressed 
some of pluripotency markers, but with a lack of uniformity. In addition, 
metaphase spreads from outgrowths showed an abnormal karyotype.  
From this study, we increased our understanding of the factors that enhance the 
derivation of bES-like cells such as the culture media and the substrates. In 
addition, we have gained more information on bovine gene expression in 
blastomere derived outgrowths. 
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Chapter One 
Introduction and literature review  
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1.1 Introduction 
The improvement in productive and reproductive traits in cattle requires 
advanced genetic technologies. Working on embryos in farm animals, 
especially dairy and beef cattle is necessary as is work on genetically  modified 
animals in order to improve animals’ traits to match the increasing demand for 
agricultural products worldwide and avoid the adult mortality that is associated 
with somatic cloning (Wells, Oback et al. 2003). In addition, farm animal can 
be a valuable source that can be used as research models for human biomedical 
research (Maherali and Hochedlinger 2008). For example, genetically modified 
organs and tissues can provide the solution for some human diseases (Keefer, 
Pant et al. 2007).   
The first embryonic stem cells (ESCs) were isolated in the mouse over twenty 
five years ago (Evans and Kaufman 1981). Since that time, there has been a 
huge amount of research in order to generate these ESCs in other species 
including domestic animals due to their potential for genetic generation (Oback 
2008). ESCs are classified depending on their ability to maintain an 
undifferentiated state, self renew, and with the ability to express pluripotency 
in vitro by the ability to give rise to all tissues and organs, and in vivo by 
teratoma formation  and the contribution to the germ cells of a developing 
foetus and subsequently, a fertilizing adult (Keefer, Pant et al. 2007). 
 ESCs can be derived by placing the inner cell mass ICM of the blastocysts into 
in vitro culture (Evans and Kaufman 1981). However, there are a number of 
aspects that make it difficult to know whether the  ICM cells are homogenously 
pluripotent and whether ESCs are formed by identical pluripotent ICM or other 
kind of cells that exist within the blastocyst (Oback 2008).   
Most attempts to culture bovine ES like cells have been to isolate them from 
the ICM of day seven blastocysts. In cattle these have been generated by in 
vitro production (IVP) system, which is a process to get immature oocytes that 
are grown in vitro through reliable procedures of maturation, fertilization and 
culture to a stage that they are able to be transferred or frozen (Galli, Duchi et 
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al. 2003). The source of embryonic cell lines is believed to reside within the 
central ICM where pluripotent epiblast tissue is located (Nichols, Silva et al. 
2009). The self renewal characteristic of ESCs depends on the activation of 
certain transcriptional regulatory networks, such as transcription factor STAT3, 
which is activated by cytokines to activate a variety of downstream genes 
(Ying, Wray et al. 2008). In the mouse, ESCs are maintained in culture by the 
cytokine; leukaemia inhibitory factor (LIF) to activate STAT3 and an inhibitor 
of differentiation: bone morphogenetic protein (BMP). However, ES cell 
differentiation occurs by the stimulation of the extracellular single regulated 
kinases 1 and 2 (ERK 1/2) pathway which is stimulated by fibroblast growth 
factor 4 (FGF4) (Ying, Wray et al. 2008). Results concluded by (Ying, Wray et 
al. 2008) found that self renewal was preserved by the blockage of the 
phosphor-ERK pathway by the use of a more chemically defined medium using 
the inhibitors (SU5402 & PD184352) (2i). The reason for that was because the 
effects of undefined growth factors and hormones are unknown. (Nichols, Silva 
et al. 2009) found that blockage of (Erk) and glycogen synthase kinase- 3 
signalling from the 8 cell stage suppresses development of the hypoblast. 
Moreover, Nanog the epiblast specific marker and an important pluripotency 
gene was expressed and pluripotency was confirmed by contribution to 
chimaeras with germline transmission.  
The use of 2i for efficient derivation of ESCs provoked the hypothesis that 
immortalising the pluripotent cells from developing embryos does not depend 
upon adaptation and selection in culture, but on the blocking of inductive 
differentiation pathways (Nichols, Silva et al. 2009). Therefore, I presume that 
cells with ESCs properties exist in the pre-implantation stage of development. 
3i /2i media have been used in late stages to assist embryos development. In the 
present study I used 2i media instead of 3i media, as it was proven that they 
have similar effects (Nichols, Silva et al. 2009). Day 2, 3, 5 and 7 embryos 
were used, and blastomeres were disassociated and single and groups of 
blastomeres were loaded in a 96 well plate in order to produce short term cell 
lines that express pluripotency markers and have normal karyotyping. 
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To achieve the goal in the present study, literature review papers are covered in 
order to have a sufficient understanding of aspects underlying pluripotency in 
bovine derived ES-like cells. Papers related to in vitro production, bovine 
embryogenesis and gene expression, ESCs in human, mouse and bovine, 
deriving ESCs in defined conditions and deriving ESCs from single blastomere 
are presented. In addition a number of markers associated with pluripotency 
and early development are provided.  
 
 
Figure (1.1): The pluripotency state when p-ERK signalling is inhibited upstream by 
the three inhibitors (CHIR 99021, PD184352 and SU5402) or downstream by LIF and 
BMP (Ying, Wray et al. 2008).  
 
1.2 Stem cells 
Stem cells have two properties, the capacity for unlimited self renewal and 
pluripotency. Theoretically, these cells can provide a supply of cells for 
transplantation. Totipotent stem cells have potentially greater utility; they are 
able to develop into all tissues and organs in the embryo and the extra 
embryonic tissues that constitute the placenta.  Tissue specific stem cells, also 
known as adult stem cells, are available throughout the body, such as in the 
bone marrow, liver, skin and brain. These cells work as a lifetime maintenance 
system to repair damage that may occur during life (Wagers, A et al. 2002). 
However, these cells can be difficult to obtain and isolate, and when isolated 
have poor growth in the laboratory making them less useful for tissue 
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engineering (Vogel 2001). In these cases, pluripotent cells may be beneficial 
because they provide a more appropriate cell source. Because of their plasticity 
and potentially unlimited capacity for self renewal, ES therapies have been 
proposed for regenerative medicine and tissue replacement after injury or 
disease. In 1964, researchers isolated a single type of cell from a 
teratocarcinoma, a tumour now known to be derived from a germ cell 
(Kleinsmith and Pierce 1964). These cells isolated from the teratocarcinoma 
grew and replicated in cell culture as a stem cell and are now known as 
embryonic carcinoma cells (ECCs). ECCs can work as a model for early mouse 
development (Illmensee and Mintz 1976). However, ECCs are cancer derived 
and usually have an abnormal karyotype, therefore, they are not suitable for 
clinical applications (Rippon and Bishop 2004). 
 
1.3 Pluripotent stem cells 
Pluripotent stem cells can be derived from embryonic, foetal and adult sources. 
Embryonic carcinoma cells (ECCs) were the first type of pluripotent cells to be 
identified, firstly from mouse (Kleinsmith and Pierce 1964) and then from 
human (Andrews 1998). ECCs are pluripotent cells derived from germ cell 
tumours. Studies on these pluripotent stem cells have led to the derivation of 
other pluripotent stem cells including embryonic stem cells from blastocyst 
(ESCs), from in vitro primordial germ cells (PGCs), from adult germ cells, 
germ line stem cells (GSCs), and from unfertilized eggs, parthenogenetic, 
(pES). Additionally, the knowledge of the genetic markers diagnostic for ESCs 
has helped to induce pluripotent stem cells from differentiated adult cells, 
which are now known as induced pluripotent stem cells (iPSCs).  All these 
different pluripotent cell lines have the general principle of pluripotent stem 
cells including unlimited proliferation and self renewal, and the ability to give 
rise to all the cells in the body from the three embryonic germ layers.  The 
production of all cell types can be accomplished by a differentiation system to 
obtain an embryoid body (EB) or pluripotent cell injection into adult mice 
(teratoma) or by chimera formation (Daley, Lensch et al. 2009). 
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1.3.1 Embryonic germ cells (EGCs) 
Primordial germ cells (PGCs) are the progenitor cells of the germ cell lineage, 
which produce gametes in the adult (Bendsen, Byskov et al. 2003). hPGCs are 
isolated from the foetal gonad about 5 to 10 weeks following gestation, to 
obtain hEGCs (Swelstad and Kerr 2010). During this time PGCs proliferate in 
order to undergo sexual differentiation into either an ovary or testis (Labosky 
and Hogan 2008). PGCs are considered to be unipotent because they are 
restricted to becoming germ cells and they do not exhibit self renewal (Dolci, 
Pesce et al. 1993).  hEGCs can be derived using the transformed mouse 
embryonic fibroblast line, Sanadoz Thioganine and Ouabain-resistant mouse 
fibroblast (STO). Recently, some attempts were made to derive human and 
mouse EGCs using mouse embryonic feeder cells (MEF) (Dolci, Williams et 
al. 1991). The derivation of EGCs requires a number of factors, including 
Forskoline to increase derivation efficiency (Swelstad and Kerr 2010), LIF to 
maintain human and mouse EGCs pluripotency, stem cell factor for mouse 
PGCs proliferation and survival (Labosky, Barlow et al. 1994), and fibroblast 
growth factor (FGF) also for proliferation and survival. Normally, EGC 
colonies can be obtained within 2 to 3 weeks, with a low efficiency rate, 
between 10%- 20% (Swelstad and Kerr 2010). In comparison to other 
pluripotent stem cells, EGCs are considered to be difficult to derive and 
maintain which hampers the progress in research in this type of cells (Swelstad 
and Kerr 2010). 
 
1.3.2 Germ-line stem cells (GSCs) 
Stevens, 1962 derived teratocarcinomas from primordial germ cells (PGCs).  
Pluripotent stem cells can be obtained from male germ cells (Guan, Nayernia et 
al. 2006), which are known as germ line stem cells (GSCs). They were first 
isolated from mouse spermatogonia (Matsui, Zsebo et al. 1992), and then they 
were derived from male testicular GSCs biopsies in 2009 (Guan, Nayernia et 
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al. 2006). Spermatogonia stem cells (SSCs) are present since birth and they 
develop from PGCs by undergoing the differentiation process which leads to 
sperm development. GSCs from adult mice can contribute to teratoma and 
chimaera formation (Labosky, Barlow et al. 1994).  Additionally, GSCs are 
similar to ESCs morphologically, and hGSCs are able to form teratoma 
(Conrad, Renninger et al. 2008), but a chimaera test cannot be performed using 
human cells. The derivation of GSCs depends on cell selection from testicular 
biopsies or spermatogonia and the utilization of cell culture substrates like 
laminin and collagen (Swelstad and Kerr 2010). GSCs have some 
characteristics of PGCs, such as genome wide demethylation, erasure of 
genomic imprints and reactivation of X chromosomes (Labosky, Barlow et al. 
1994).  The long history of studying SSCs contributes to the success in deriving 
GSCs (Dym, He et al. 2008).  GSCs can provide an adult source for pluripotent 
stem cells which is easier to use for clinical applications. However, they can 
only be used in male patients (Swelstad and Kerr 2010). 
 
1.3.3 Parthenogenetic stem cells (pESCs): 
Parthenogenesis can be defined as the development of a diploid embryo from a 
female gamete without the contribution from a male (Swelstad and Kerr 2010). 
Parthenogenesis occurs in some invertebrate and vertebrate species naturally, 
but it is rare in mammals.  This process can be induced in vitro using ethanol, 
ionomycin or cycloheximide, which induce Ca
+2
 oscillations. Additionally, it 
can be induced using physical stimulation, including mechanical stimulation, 
cold temperature treatment and electrical shock (Rougier and Werb 2001). 
Also, cytoskeletal inhibitors (6-dimethylaminopurine) are needed to keep the 
second polar body to create a diploid cell like zygote (Swelstad and Kerr 2010). 
The lack of paternally derived genes leads to the inability of parthenogenetic 
embryos to develop past an early post implantation stage (Surani, Barton et al. 
1984). But, Wu and colleagues were able to use the appropriate imprinting 
genes which help to produce offspring (Wu, Kumagai et al. 2006). In addition, 
the first human specific pESC lines were produced in 2008, in which they 
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expressed pluripotency markers, and were able to differentiate to cells from the 
three germ lines and induce teratoma formation (Revazova, Turovets et al. 
2008). 
Recent research demonstrates that pESCs are able to be derived at rates 
approaching 10%-16% (De Sousa, Gardner et al. 2009). Haploid 
parthenogenetic embryos can also be created by eliminating the cytoskeletal 
inhibitor step to extract the second polar body after oocyte activation. By this 
process, obtaining heterozygous pESCs can be avoided (Revazova, Turovets et 
al. 2008). 
The culture conditions and the derivation system resemble those of ESCs. The 
system of ICM isolation and cell culture are similar to ESCs. To culture pESCs 
they need either human or mouse fibroblast feeder, and growth media including 
human serum or serum replacement. LIF is not required to derive pESCs (Lin, 
OuYang et al. 2007).  The positive factor associated with those cells is that they 
can be produced successfully from fresh oocytes, which make these cells 
beneficial for women able to produce oocytes (Swelstad and Kerr 2010). 
However, recently pESCs were obtained using cryopreserved oocytes, 
suggesting that this could be promising in the treatment of elderly women and 
women diagnosed with cancer (Fengying, Zhenfu et al. 2009). 
 
1.3.4 Induced pluripotent stem cells (iPSCs) 
The production of iPSCs involve the use of somatic cells and and the 
introduction of certain gene expression for reprogramming, to enable these 
cells to be pluripotent or embryonic (Swelstad and Kerr 2010).  Lineage 
reprogramming can occur naturally in lower vertebrates and in mammals as 
well, by dedifferentiation, in which a differentiated cell reverts to an early stage 
of development, and transdifferentiation in which a differentiated cell turns into 
to another type. The study of natural transdifferentiation may help reveal the 
molecular machinery that underlies reprogramming. That can be used to 
improve and develop better reprogramming mechanisms (Swelstad and Kerr 
2010). The first iPSCs were produced in 2006 by Yamanaka. Since then, iPSCs 
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were able to be derived in mouse, human, rat and monkey cells, using 
transcription factors. The original method used viral integration to facilitate the 
appropriate gene expression (Swelstad and Kerr 2010). However, this 
technique cannot be suitable for clinical applications, because of the use of the 
viral fusion technique. Recently, iPSCs have been produced using transduction 
with proteins, or by the use of nonintegrating vectors that express 
reprogramming factors. To reprogram somatic cells, numbers of pluripotency 
genes are used including NANOG, OCT4, and SOX2 and additionally some 
oncogenic factors like KLF4 and c-MYC (Amabile and Meissner 2009). The 
studies on iPSCs demonstrated the requirement of SOX2 and OCT4 for 
somatic cell reprogramming, and the use of KLF4 and c-MYC for better 
efficiency (Swelstad and Kerr 2010). The major problem associated with iPSCs 
is the possibility that these cells will generate a tumour later on. That is because 
of the integration of oncogenic factors into the host genome. To avoid this 
issue, transfection is used by the utilization of chemical inhibitors to reprogram 
proteins (Stadtfeld, Nagaya et al. 2008).  Chemical inhibitors are used for DNA 
methylation, histone methylation and acetylation to improve reprogramming 
efficiency (Stadtfeld, Nagaya et al. 2008). However, chemical reagents are not 
enough for full programming and they can introduce some modifications that 
result in deregulation of genes (Palii, Van Emburgh et al. 2008).  It takes 
approximately 1 to 4 weeks to generate iPSC-like colonies after transfection. 
Then these colonies are selected for clonal propagation depending on their 
morphology. Another 4 weeks are needed for pluripotent gene expression, and 
then the process of selection is started depending on the expression of cell 
surface markers including TRA-1-60, TRA-1-81 and SSEA4 (Brockes and 
Kumar 2002). The low success rate of transformation is another issue. 
Transformation can provide between 0.001% to 0.1% efficiency rates. 
However, the addition of other molecules can improve the efficiency of 
transformation to about 3% in human iPSCs and 10% in mouse iPSCs 
(Stadtfeld, Nagaya et al. 2008).  Additionally, the use of cells from an earlier 
developmental tissue can improve the efficiency of transformation by 
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approximately 8 fold.  Although the generation of iPSCs brings a greater hope 
for therapeutic uses and avoids the use of embryonic material, still there is an 
urge to find better pluripotency regulation and cellular reprogramming 
mechanisms (Swelstad and Kerr 2010). 
 
 
 
Figure (1.2): Different types of human pluripotent stem cells and their derivation 
systems including embryonic stem cells derived from blastocyst, embryonic germ 
cells generated from primordial germ cells, embryonal carcinoma cells isolated from 
adult teratocarcinoma, germ line stem cells derived from spermatogonia and induced 
pluripotent stem cells produced by reprogramming unipotent cells (Swelstad and Kerr 
2010).  
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1.3.5 Embryonic stem cells (ESCs) 
Embryonic stem ESCs are pluripotent cells that are capable of differentiating 
into cells of all three germ layers lineages in vitro and in vivo (Martin 1981). 
These cells can divide symmetrically and self renew, therefore, they can 
provide an unlimited source of any type of cells.  Totipotency is defined as the 
capacity of a single cell to produce fertile offspring. This totipotency is lost 
when a cell becomes more specialised, and becomes pluripotent, unipotent, and 
finally a specialised cell. The totipotent cell is able to divide on its own and 
produce tissues for foetal development and implantation. Mouse embryonic 
stem ESCs were first described about 20 years ago. They were isolated from 
the inner cell mass ICM of the developing blastocyst and grew in vitro (Evans 
and Kaufman 1981; Martin 1981). ESCs can contribute to all cell lineages, 
including the germ line (Nagy, Gocza et al. 1990). In vitro, ESCs can 
proliferate in the undifferentiated state indefinitely, unless they are induced by 
appropriate signals. In this case, they will differentiate to all mature somatic 
phenotypes.  ESCs can provide a model system for studies of early embryonic 
development and cellular differentiation (Rippon and Bishop 2004). Also, they 
can be used in cell therapies to provide a source of cells or tissues in the 
laboratory. This new era in therapy can solve many problems associated with 
diseases, organ damage, and the body’s repair. ESCs are isolated from the inner 
cell mass ICM of a day 5 to 7 blastocyst. The quality and the quantity of the 
ICM are important to obtain ESCs (Lerou, Yabuuchi et al. 2008).  ESCs lines 
are mostly obtained from IVF embryos, for human ESCs this is an issue 
because of the poor quality of these embryos.  Daley et al. have reported a 
better method used to obtain ESCs from embryos considered to be not optimal 
for implantation by using hypoxic conditions (Daley, Peters et al. 2008; Lerou, 
Yabuuchi et al. 2008).  Yamanaka had a similar finding with iPSCs production 
under hypoxic conditions (Lerou, Yabuuchi et al. 2008). In addition, in order to 
eliminate more stress from these poor embryos, manipulation techniques can be 
avoided such as immunosurgery. The derivation of hESCs using animal 
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materials, limits the use of these cells in cell therapies. Therefore, using animal 
free conditions, serum free and feeder free medium is advised. 
 
Pluripotent stem cells  Source 
Embryonic stem cells blastocysts, early stages of development 
Epiblast stem cells Epiblast 
Induced pluripotent stem 
cells Unipotent cells 
Embryonal carcinoma 
cells teratocarcinoma 
Parthengenic stem cells  chemically activated unfertilised oocyte 
Germline stem cells  
spermatogonia stem cells from fetal or adult 
males 
Embryonic germ cells primordial germ cells (mouse only) 
 
Table (1.1): Different types of pluripotent stem cells. 
 
 
1.4 MOUSE EMBRYONIC STEM CELLS (mESCs) 
Early mouse embryos have the ability to form teratocarcinomas if they are 
transferred to extra-uterine sites like kidney (Stevens 1970). This ability of 
mouse embryos points to the fact that they have a group of cells that can 
develop into pluripotent stem cells. mESCs were first derived from the ICM of 
mouse blastocysts using fibroblast feeder layers and serum (Evans and 
Kuafman, 1981, Martin, 1981). These mESCs are karyotypically normal cells 
and can contribute to cells of all three germ lines. This mechanism enables the 
modification of the mouse germ lines (Bradley, Evans et al. 1984). In mice, the 
ability to derive ESCs is largely affected by mouse strain type (Ledermann and 
Bürki 1991). Additionally, mESCs can be derived from early cleavage stage 
embryos and from a single blastomere from two to eight cell stage embryos 
(Chung, Klimanskaya et al. 2006). To obtain mESC lines, the culture system 
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needs to be supplemented with two protein kinase inhibitors. The first one: is 
PD0325901 that blocks mitogen- activated protein kinase (ERK/MAPK) signal 
pathway to block differentiation (Chung, Klimanskaya et al. 2006); the second 
one is CHIR 99021, which acts through bFGF to up regulate the glycogen 
synthase kinase (GSK) (MEK/ERK) pathway to promote proliferation and self 
renewal (Kang, Kim et al. 2005). (Hanna, Markoulaki et al. 2009), derived LIF 
dependent mESC (NOD strain) by using two systems: up regulation of C-MYC 
and KLF4; or supplementing the medium with small compounds that activate 
the C-MYC and KLF4 pathways. The first component is CHIR (has similar 
action to C-MYC), which inhibits the GSK pathway. The second is 
kenpaullone (KP), which is a selective inhibitor of GSK and cycline (Hanna, 
Markoulaki et al. 2009), which substitutes for KLF4 actions. By these systems, 
LIF dependent mESC were obtained and chimaeric mice were acquired. LIF is 
not enough to stop differentiation of mESCs in serum free medium, bone 
morphogenetic protein (BMP), a member of the TGFβ family, is also required 
(Ying, Nichols et al. 2003). BMP acts through the S mad pathway to induce the 
expression of the inhibitor of differentiation (Yu and Thomson 2008). Epiblast 
ESCs (EpiSCs) are different to mESCs, in that they are isolated from day 5.5 to 
6.5 post implantation mouse embryos. However, they resemble hESCs in terms 
of culture requirements, gene expression and pluripotency tests. 
 
1.5 Human Embryonic stem cells (hESCs) 
Human ESCs are derived in a similar way to that of mouse ESCs.  Initially, 
human ICM was cultured in media supplemented with LIF and serum, which is 
suitable for mESCs derivation and culture, but not for hESCs, and resulted in 
differentiation (Yu and Thomson 2008). In 1995, ESCs were derived from 
rhesus monkey and marmoset (Thomson, Kalishman et al. 1996). The research 
on those cells has enabled the culture conditions of IVF embryos to be 
improved (Gardner, Schoolcraft et al. 1998), which led to the derivation of 
hESCs (Thomson, Itskovitz-Eldor et al. 1998). hESCs have been derived from 
morula, blastocyst (Stojkovic, Lako et al. 2004), single blastomeres (Irina, 
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Young et al. 2006) and parthenogenetic embryos (Lin, OuYang et al. 2007). 
However, it has not been determined yet if these different pluripotent cell lines 
have equivalent developmental potential (Thomson, Itskovitz-Eldor et al. 
1998). To culture hESCs, mitotically inactivated fibroblast feeder layers and 
serum medium were used in both mouse and human ESCs. However, LIF is 
only used for mouse, because hESCs do not express the LIF pathway, LIFR, 
gp130 and JAK1 and 2 (Brandenberger, Wei et al. 2004), and STAT3 is 
activated at a low level (Dahéron, Opitz et al. 2004). The BMP pathway 
components are all present in hESCs, but the addition of BMPs to the culture 
medium will introduce differentiation (Xu, Chen et al. 2002). For self renewal, 
FGF and TGFβ/ Activin / Nodal are critical for hESCs, like mouse epiblast 
ESCs (Brons, Smithers et al. 2007). bFGF has a positive regulation effect on 
the expression of TGFβ in the feeder layer and hESCs, which enhances hESCs 
self renewal (Greber, Lehrach et al. 2007). Activin and TGFβ promote 
undifferentiated proliferation of hESCs in lower concentrations of FGFs 
(Beattie, Lopez et al. 2005). 
 
1.6  BOVINE EMBRYONIC LIKE STEM CELLS (bES-like cells) 
Research in bovine ES-like cells have established since 1996 (Mitalipova, 
Beyhan et al. 2001), to create models for human genetic diseases, and cell 
transplantation therapies. In addition, bES-like cells can provide useful tools to 
improve animal traits, products, and for disease resistance, which can be 
obtained by somatic cell nuclear transfer (SCNT) or by chimaera formation. 
However, to this day it is still unknown if these cells can be produced in vitro 
(Roach, Wang et al. 2006). The poor results may be due to some issues with the 
starting materials such as, embryos produced from an in vitro system and the 
treatments for bES-like cells maintenance in vitro.  ESCs were first established 
from in vivo day 3.5 mouse embryos in 1981 (Evans and Kaufman 1981). ESC 
lines were also derived from human (Thomson, Itskovitz-Eldor et al. 1998). In 
the 1990s, there were attempts to derive ESC from porcine ICM, but there was 
no proof that these cells were pluripotent (Notarianni, E et al. 1990). The 
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success in obtaining ESC from primates encouraged workers to obtain similar 
lines from other species, including sheep (Notarianni, E et al. 1990). 
Unfortunately, successful ESC lines were only obtained from another rodent 
species, the rat (Buehr, Meek et al. 2008). The efforts attempted in another 
species did not result in true ESC lines, because these cells were not able to 
proliferate and, or differentiate to all cell types from the three germ layers 
(mesoderm, endoderm, and ectoderm) (Wobus and Boheler 2005).  ESC from 
domesticated ungulates such as cow could be a beneficial tool for agriculture, 
and for regenerative medicine. Large species like cow can be better models for 
human diseases than the rodents, because organ size, physiology and anatomy 
are more similar to humans, which can be introduced into recipients for 
transplantation issues. In addition, the ability to knock in and knock out genes 
can create good models in order to study gene functions. For agricultural 
benefits, production genes can be modified to bring more commercial value.   
However, it has been difficult to derive bESCs lines up to now, and there has 
not been any bESCs lines reported (Keefer, Pant et al. 2007). In cattle, most 
attempts to isolate ESC were from blastocysts (Stice, Strelchenko et al. 1996) 
and from 12-14 embryos with an embryonic disc(Gjorret and Maddox-Hyttel 
2004). Additionally, some attempts used early cleavage embryos starting from 
the two cell stage to the morulae stage to derive ESC. Most of these attempts 
failed (Mitalipova, Beyhan et al. 2001) except for one from a 16 cell stage 
embryo, that survived for 9 months (Stice, Strelchenko et al. 1996), and another 
one from a 2 cell stage embryo that survived for 3 years (Mitalipova, Beyhan et 
al. 2001). In terms of differentiation, those cell lines were able to differentiate 
as they formed embryoid bodies, but they could not form teratomas.  Although 
these cell lines were able to survive for a period of time and had a restricted 
ability to form teratomas, they were not considered to be true ESC. The poor 
results obtained can be related to the stage of derivation and/or the culture 
medium.  There are a number of factors that contribute to the difficulty to 
sustain bES-like cells in culture for a long time. These factors can be related to 
features of both intrinsic and extrinsic embryonic development. 
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1.6.1 Intrinsic factors 
1.6.1.1 Developmental competence 
 True ES cell lines were only obtained from two strains of mouse; strains 129 
and CS7BL16. EpiSC had been derived from only two other species, human 
and monkey (Thomson, Itskovitz-Eldor et al. 1998). (Telugu, Ezashi et al.) 
believed that mESC are laboratory artefacts that were selected by chance and 
by improvements in the culture conditions of the early stages of outgrowth. 
However, genetic background information enabled the understanding of the 
development requirements of mouse and therefore, improves the culture system 
for mESC. Mouse can be a model that can be used to understand pluripotency 
networks and the factors that contribute to it. This understanding can be applied 
to other species, and may contribute to the improvement in the culture 
requirements. 
 
1.6.1.2 Differences in developmental timing 
Early embryonic development up to epiblast formation is not similar in 
different species, especially between mouse and cow. The time of 
differentiation is different, the first differentiation to occur in mouse takes place 
by day 3.5, and an additional layer of cells is formed called extra embryonic 
endoderm. All of these three layers are formed by day 5 in mouse, but this is 
not the case in other species. In human and cow, blastocysts formation takes 
place several days after mouse. Mouse form the epiblast structure by the 
proliferation of the ICM cells by day 6, and gastrulation is initiated on day 6.5. 
However, distinguishing between the ICM and the epiblast is difficult in cows. 
In cows, the ICM is smaller than the TE, but ICM cells proliferate to form 
epiblast by day 7-8 (Hall, Christensen et al. 2009) and then persist for a long 
time. Additionally , a thin layer of TE cells overlaying the epiblast (Rauber’s 
layer) degenerates by day 12 in cow, exposing the epiblast to the uterine lumen 
contents (Maddox-Hyttel, Alexopoulos et al. 2003). The loss of the Rauber’s 
layer coincides with rapid growth of the embryo. In the mouse, attachment to 
 16 
 
the uterus occurs by day 4.5, while in cattle this period is extended to14 days, 
and full attachment occurs by day 21. Lastly, the development in cattle is not 
like mouse and human. There is a longer time for trophoblast expansion, 
whereas the embryo expansion is delayed. Furthermore, because the epiblast is 
not enclosed within the trophoblast and exposed to the uterus fluid, the 
nutritional requirements can differ in bovine, rodent and human. That is why it 
is not easy to select the appropriate stage at which to derive bES-like cells, and 
develop culture requirements. 
 
1.6.1.3 Lack of pluripotency markers: 
Early embryology and molecular factors that accompany each decision in cattle 
are not fully known. Molecular markers and surface markers in human and 
rodent are more specific to the species, that is why they may not be completely 
accurate for detecting bES-like cells. NANOG is an important pluripotency 
marker that has been detected in mouse and human ESC (Mitsui, Tokuzawa et 
al. 2003). NANOG is also detected in bovine blastocysts, ES like cells  and in 
both ICM and TE (Muñoz, Rodríguez et al. 2008). SOX2 transcripts are 
specific for epiblast (Prasanna Kumar personal communication), but there are a 
number of papers suggesting that it is also expressed in the trophoblast 
(Magnani and Cabot 2008). Additionally, bovine OCT4 expression is not like 
mouse, because it is expressed in both the ICM and TE, and continues to be 
expressed in the TE for a longer time in cattle (He, Pant et al. 2006) until day 
12 which then is only expressed in the epiblast (Gjorret and Maddox-Hyttel 
2004). Therefore, OCT4 is considered to be a pluripotency marker for ICM and 
epiblast. Surface markers, stage specific embryonic antigens (SSEA1, SSEA3, 
SSEA4), and keratin sulphate antigens (TRA-1-60, TRA-1-80) transcripts are 
localised in both the bovine ICM and TE. Therefore, bES-like cells lack 
specific pluripotency markers (Keefer, Pant et al. 2007). It is important to 
check a wide list of markers to define bES-like cells, which may be not 
consistent with human and mouse ESC markers. 
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1.6.2 Extrinsic factors: 
1.6.2.1 Mixing cell types: 
bES-like cells are usually derived from isolated ICM from day 7 or 8 
blastocysts using the mechanical or immunosurgery systems, and from earlier 
stages of development including 2,4,8,and16 cells. However, it is possible that 
the isolated ICM cells had some degree of contamination with other cells like 
TE cells. (Talbot, Powell et al. 1995) presented that the contamination with TE 
can be sufficiently high to exceed the number of ICM cells.  
 
1.6.2.2 Culture conditions: 
The use of a mouse and, or human feeder layers to derive bES-like cells may be 
inappropriate. The use of heterologous culture cells like STO and mouse 
embryonic fibroblast (MEF) is still questionable (Brevini, Gandolfi et al. 
2007). These heterologous factors might not be effective in supporting bES-
like cells, and still more research is needed to find out better culture systems 
for the growth of bES-like cells. hESCs need basic fibroblast growth factor 
(bFGF) and a feeder layer for proliferation and do not require leukaemia 
inhibitor factor (LIF), while mESC depend on LIF (Dahéron, Opitz et al. 2004). 
(Vejlsted, Avery et al. 2005) reported that human LIF is essential for bES-like 
cell derivation. Human LIF has been reported to have negative effects on bES 
like cells  (Vejlsted, Avery et al. 2005). Although, signals to maintain 
pluripotency in mouse and human cells are clear, it remains elusive in bovine. 
So, the combination of ICM derived ESC and the epiblast derived ESC 
medium additives, 2i in bovine, may up regulate the LIF/STAT3 signalling 
pathway and promote the outgrowth of bES-like cells. 
 
 
1.7 Deriving ESCs in defined conditions 
The unique feature of ESCs is their ability to differentiate in vivo and in vitro 
into many cell types. Therefore, they provide a useful tool to study 
development and can be used in clinical therapies. Banks of hESC lines with 
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different human leukocyte antigen (HLA) were established to provide hESCs 
consistent for clinical therapy. Additionally, nuclear transfer NT may be able to 
generate homologous ESCs in the future and provide cells for regenerative 
medicine (Dvash, Mayshar et al. 2004). Tissue culture technology was 
established in 1950s (Ludwig, Levenstein et al. 2006). Mitotically inactivated 
fibroblasts were first used to support HeLa cells, the oldest and the most 
commonly used human cell line derived from cervical cancer (Ludwig, 
Levenstein et al. 2006). Later on ESCs and mouse carcinoma were cultured on 
feeder layers. It was lucky that fibroblast feeder layers support both human and 
mouse ESCs. hESCs lines are usually derived in a medium with animal 
products, which may cause a number of problems as (Lu, Hou et al. 2006) 
mentioned. Firstly, ESC lines may contain immunogenic or/ and toxic proteins 
that may cause immune responses and lead to rejection of the transplant tissue 
and organs. Animal products express Neu5Gc, which is a non human 
immunogenic sialic acid on cells for human transplantation. Secondly, the 
isolation of hESCs from the feeder layer is time and labour consuming. Finally, 
undefined conditions may cause complications in developmental studies. 
Therefore, it is important to use a defined culture system to derive hESCs 
without the use of animal products. The derivation of hESCs need a number of 
requirements such as, bFGF for self renewal, a feeder layer and condition 
medium or cytokines such as TGF or Wnt3a, matrix and FCS or serum 
replacement. (Lu, Hou et al. 2006) developed a mixture that had chemically 
synthesized recombinant and human derived factors to support hESCs growth, 
which they named hESC Cocktail. In addition, other groups have reported the 
use of defined culture conditions including (Ludwig, Levenstein et al. 2006). 
 
 
1.8 The extra cellular matrix (ECM) 
The extra cellular matrix (ECM) is the structure that gives multicellular 
organisms their strength and keeps cells in their correct positions. Organisms 
are formed from many types of tissues; these tissues are connected to each 
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other by the ECM at special places called cell-cell junctions (Alberts, Johnson 
et al. 2002). The natural extra cellular molecules ECM are important to support 
tissue structure, function and organs in vivo and in vitro to direct cell fate and 
behaviour (Lutolf and Hubbell 2005). In addition, they have a number of roles 
in regulating cellular functions such as proliferation, growth, migration, 
morphogenesis, differentiation, gene expression and survival (Lutolf and 
Hubbell 2005). The ECM is composed of proteins that are secreted from 
neighbouring cells to form an organized network. The ECM concentrate on 
connective tissues and the amount of ECM varies greatly between different 
organs. The variation in the components of the ECM leads to different types of 
matrix molecules, each with different functions. ECM from fibrous proteins 
including collagen, fibronectin and laminin, has mainly adhesion functions 
(Alberts, Johnson et al. 2002). Each type of matrix is not appropriate to support 
all cell types (Hughes, Postovit et al. 2010).  ECM can be extracted from living 
cells to be used for more sensitive types of cells (Hughes, Postovit et al. 2010). 
In addition, advanced tissue engineering enables the design of artificial 
materials which resemble the natural environment. To obtain a clinically 
acceptable source of ESCs, they need to be derived in fully defined conditions.  
To derive ESC in defined conditions, surface coating is needed to act as an 
attachment material for ESC. Surface coatings consist of a combination or 
individual ECM proteins, such as laminin-11, collagenIV, gelatin, Marigel and 
fibronectin, which are not fully defined and homospecific (Domogatskaya, 
Rodin et al. 2008). ECM components are important in regulating ESC self 
renewal and in maintaining pluripotency. ECM is regulated by the integrin 
family of cell surface adhesion receptors (Hynes 2002). Integrin induced by 
cell-ECM interactions are important for pluripotency maintenance and viability 
(Almeida, Huovila et al. 1995). Integrin-ECM interactions act through integrin-
liked kinase (ILK) or focal adhesion kinase (FAK) signalling pathways, and 
additionally through the activation of PI3K/Akt and MAPK pathways (Ramirez 
and Rifkin 2003).  
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Members of the integrin family are expressed in patterns depending on their 
function during embryogenesis (Hayashi, Furue et al. 2007). For instance, 
integrin β1 is essential for ICM proliferation (Hayashi, Furue et al. 2007).  
 
1.8.1 COLLAGEN 
The collagens are the most common matrix in all multi-cellular animals. They 
are secreted by the connective tissue and other cell types. Collagens are the 
major protein component of bone and skin, and they form about 25% of the 
proteins in animals. The collagen molecule is long with a triple helical 
structure, in which three α chains are wound around each other. There are 25 
different types of collagen α chain, which make about more than 10,000 types 
of collagen only 20 have been identified so far including type I, II, V and XI. 
Collagen I is important for bone and skin structure. For example, types IX and 
XII create the surface of collagen fibers whereas type VI and VII are network 
forming collagen. Collagen type I and IV have been reported to maintain 
pluripotency in mouse ESCs (Alberts, Johnson et al. 2002). 
 
1.8.2 FIBRONECTIN 
Fibronectin is a large glycoprotein which is found in most if not all vertebrates. 
It helps to organise the matrix and regulate the attachment of cells to it. The 
main type of fibronectin is type III. Fibronectin that exists in soluble forms 
helps in blood clotting and phagocytosis, while the fibrillar form assemble on 
the cell surface and are deposited in the ECM. There are some proteins that 
prevent fibronectin assembly in inappropriate places such as, ultroglobin. 
Fibronectin is very important in early development. That was proved by gene 
inactivation experiments in mice (Alberts, Johnson et al. 2002). These mice 
were unable to form fibronectin and therefore died during embryogenesis 
because they were not able to form proper blood vessels. That can happen 
because of the lack of interaction between cells and the surrounding ECM, 
which usually have fibronectin (Alberts, Johnson et al. 2002).   
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1.8.3 LAMININ: 
Laminins are components of basement membranes, which are the first substrate 
to attach to the early stages of embryonic development, starting from two to 
four cells in murine embryos (Hayashi, Furue et al. 2007). Mice that lack 
laminin, die early during embryogenesis because they are unable to form basal 
lamina.  Laminin 511 is one type of the laminins that attach to the ICM of the 
blastocysts and promote adhesion and proliferation (Rodin, Domogatskaya et 
al. 2010).  Therefore, laminins are useful molecules in culturing ESC in vitro. 
Laminin-1 is a large protein that composed of very large polypeptide chains (α, 
β, and γ). These chains can arrange differently to form distinct types of laminin.  
About 15 different combinations of these macromolecules have been found 
(Rodin, Domogatskaya et al. 2010). Each type of the laminins has different 
locations and functions, some presented in early embryos, or epithelial cells, or 
in tumour cells (Domogatskaya, Rodin et al. 2008). Laminin-511 is common in 
basement membranes in embryonic stages such as ECM between cells in the 
ICM of the blastocysts (Domogatskaya, Rodin et al. 2008), and in adult tissues 
as well (Hayashi, Furue et al. 2007). Laminins are important for cell adhesion, 
proliferation, migration and apoptosis resistance, which make them an 
appropriate candidate for ESC culture (Domogatskaya, Rodin et al. 2008). The 
linkage between these different types of laminins and other macromolecules 
makes it difficult to isolate them (Domogatskaya, Rodin et al. 2008). However, 
there are a number of laminins that can be extracted including, laminin 111, 
laminin 211, laminin 322, laminin 411. (Domogatskaya, Rodin et al. 2008) 
found that laminin 511 is capable of facilitating mESC self renewal for more 
than 150 days, even in the absence of differentiation inhibitors.  
 
1.8.4 MATRIGEL 
Matrigel is a combination of factors and not a fully defined mixture of extra 
cellular matrix proteins that were extracted from the Englbreth-Holm-Swarn 
mouse tumours (Hughes, Postovit et al. 2010). It consists of laminin, collagen 
IV, fibronectin and a number of growth factors such as FGF2, EGF,EGF, 
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PDGF, NGF and TGF-β (Hughes, Postovit et al. 2010). One of the important 
roles of matrigel is its use for growing ESC; because of its ability in mimicking 
the cell-ECM interactions in vivo (Hughes, Postovit et al. 2010). However, 
(Mieszawska and Kaplan 2010) reported that it can limit ESC development. It 
is used in the culture of pluripotent stem cells, but it can be use to induce 
differentiation, increase tumour growth, and support duct formation. However, 
it has variable components that differ from patch to patch, which can affect 
reproducibility of the culture system and the safety standard of pluripotent stem 
cells that is used in cell therapy (Hughes, Postovit et al. 2010). Matrigel can be 
replaced with more purified components including IV collagen, fibronectin, 
laminin and vitronectin in combination or alone. In addition some substrates 
have been reported to support hESCs pluripotency and the binding with 
integrins including vitrovictin collagen  and laminin-511(Nagaoka, Si-Tayeb et 
al. 2010). 
 
1.9 Deriving bovine embryonic stem like cells from a single blastomere  
Using stem cells in human for cell therapy and to repair damaged tissues is 
real. However, the use of stem cells is a problematic topic involving ethical and 
political issues. There is a division among the public and politicians, whether it 
is ethical to use ICM to create hESC lines because it involves destroying 
embryos. However, the use of one or two blastomeres from a pre-implantation 
embryo to produce stem cell lines may solve this problem as it does not involve 
embryo destruction. Additionally, isolated blastomeres from mammalian 
embryos have other significant applications. Isolated blastomeres can be used 
for genotype analysis for superior animals, for sex determination, and screening 
for genetic disorders as for pre-implantation genetic diagnosis (PGD) (Chung, 
Klimanskaya et al. 2006; Simpson 2006). PGD is a common technique used to 
detect genetic diseases. The technique involves the removal of a single 
blastomere from an 8 cell stage embryo through a hole in the zona pellucida. 
The single balstomere is then analysed to detect genetic abnormalities. If there 
was no abnormality, the 7 blastomere embryo is then transferred to the mother 
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uterus to produce the foetus. In addition, PGD can be used to decrease 
miscarriage, increase implantation rates and increase live birth in some 
situations. Normally, the embryo is transferred back to the uterus within 24-48 
hr., but the time can be extended to the blastocyst stage. The removal of a 
single blastomere will not affect the implantation and development of the 
embryo, because only one blastomere is removed from the embryo. However, it 
is beneficial to culture the isolated blastomere with its parent embryo up to the 
blastocyst stage to enhance blastomere division and the derivation of ESC 
lines. However, this may affect the implantation procedure because of the long 
culture in vitro, which is not similar to the normal environment. The milieu of 
the human reproductive system has positive effects on promoting the 
expression of the correct genes and the imprinting pattern. The pluripotentcy of 
single blastomeres can be determined by the transfer into the uterus. Offspring 
have been produced from 2 cell stage mice embryos (Geens, Mateizel et al. 
2009). Four cell stage bovine embryos are the only example able to be 
developed into live offspring (Johnson, Loskutoff et al. 1995). (Moore 2006) 
found that about 33% of the blastomeres derived from 4 to 6 cell porcine 
embryos continue their development normally in vivo. However, it is still 
unknown when blastomeres lose their totipotentcy during pre-implantation 
development. (Lorthongpanich, Yang et al. 2008) found that blastomeres from 
early stage embryos do not have equal competence for development. In 
addition, single blastomeres are not equally competent to continue development 
and to express ICM markers (Lorthongpanich, Yang et al. 2008). In addition, 
lower rates of development have been observed in vitro. ESC lines are usually 
derived from blastocyst stage embryos, which involve the destruction of human 
embryos. However, use of a single blastomere was the method that allowed 
stem cell line derivation and preserved the embryo to continue its implantation 
and development. This technique was done firstly in mice by (Chung, 
Klimanskaya et al. 2006), and then in the human by (Irina, Young et al. 2006). 
Three different cell fates were observed when using this system to obtain ESC 
lines; 1- cells resemble a trophoblast cells, 2- cells similar to ESCs, but they 
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start to differentiate and 3- cells similar to ESCs and contribute to proliferation 
and express ESCs markers. These normal ESCs were able to differentiate into 
cells from the three germ layers, and form teratomas. Further study is needed to 
find out whether these cell lines are different from blastocyst derived ESC 
lines. However, the downside of this system are: 1- possibility of causing 
damage to the embryo during cell removal, 2- the embryo may not respond to 
the procedure, 3- the use of surplus IVF embryos, which usually have genetic 
defects and 4- the low success rate compared to the blastocyst derived ESC 
lines (Chung, Klimanskaya et al. 2006; Irina, Young et al. 2006; Simpson 
2006). Ethical and political complications in the use of human embryos may 
not apply for cattle embryos. However, the use of this system in bovine may be 
beneficial because it has been a challenge to obtain the naive state of ESCs in 
bovine. This can be attributed to a number of factors such as, the long period 
before implantation, the lack of sufficient information about an optimal culture 
system and the lack of specific bovine pluripotency markers. Thus, it is useful 
to investigate the pluripotency of blastomeres derived from early bovine 
embryos. In addition, a large number of bES-like cell lines can be obtained 
from a few embryos. Furthermore, this system allows genetic diagnosis of the 
resulting cell lines before obtaining them.  
 
Figure (1.3): Derivation method of ESC lines. (b): from single blastomere, (c): from 
blastocyst (Simpson 2006). 
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1.10 Markers detected in bovine outgrowths: 
1.10.1 NANOG 
LIF maintains self renewal of mouse ESCs by the activation of Stat3, but it is 
not sufficient to maintain pluripotency alone. Thus, this pathway is not 
essential for pluripotency. Many genes have been found to maintain 
pluripotency, but none of them is independent of LIF/Stat3 function. OCT4 is a 
Pou family transcription factor that is expressed in pre-implantation embryos, 
ESCs, epiblast and germ cells (Scholer, Dressler et al. 1990). Suppression of 
OCT4 induces differentiation (Hitoshi, Jun-ichi et al. 2000). OCT4 over 
expression causes differentiation, which resembles the one caused by Stat3 
inactivation, suggesting interaction between the two transcription factors. 
SOX2 also functions with OCT4 (Guo, Costa et al. 2002), which indicates a 
cross link with Stat3. The LIF/Stat3 pathway is an independent factor that 
determines pluripotency in both the ICM and ESCs. Nanog is a transcription 
factor that works independently of the LIF/Stat3 pathway. It contains a 
homedomain protein of ESC self renewal and is also expressed in early 
embryonic stages. Nanog was named after the land of the ever young (Tir nan 
og). Nanog cDNA has 2184 nucleotides with a single open reading frame 
encoding a polypeptide of 305 amino acids. It has a long un-translated region 
with a repetitive element. Nanog null cells differentiate into endoderm. It has 
regulation effects in maintaining ESCs pluripotency. It works independently 
from the LIF/Stat3 pathway to prevent differentiation into endoderm cells. In 
pre-implantation embryos, Nanog expression is low and OCT4 is the 
transcription factor that determines cell fate. At the blastocyst stage Nanog is 
expressed in the ICM to cause the cells to remain pluripotent. However, it is 
not sufficient to maintain pluripotency without LIF/STAT3 signals.  
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1.10.2 SOX2 
In mouse and human ESCs, OCT4, SOX2 and NANOG are involved in 
pluripotency maintenance and have a common target site in the regulatory 
regions of a number of genes. SOX2 repression in mESCs induces 
trophectoderm differentiation (Masui, Nakatake et al. 2007), but over 
expression of SOX2 causes non specific lineage differentiation, neuronal 
differentiation and cell death (Kopp, Ormsbee et al. 2008). SOX2- null mice 
enable the maintenance of the ICM and trophoblast development (Avilion, 
Nicolis et al. 2003), suggesting that SOX2 is important for both, ESCs 
maintenance and trophoblast development. Additionally, reduction in SOX2 
expression in hESCs causes differentiation of ESCs with an increase in 
trophetoderm markers (Fong, Hohenstein et al. 2008). Also, suppression or 
over expression of SOX2 in hESCs causes trophectodermal differentiation, 
which indicates the important role of SOX2 in the maintenance of trophoblast 
development (Adachi, Suemori et al. 2010). 
 
1.10.3 OCT4 
OCT3/4 is a transcription factor that is encoded by the POU5F1 gene from the 
Pou-homeodomain family. It has an essential role of regulating pluripotency 
during early development (Morrison and Brickman 2006). OCT3/4 is expressed 
in embryo including epiblast and primordial germ cells, ESCs and EGCs (Pesce 
and Schöler 2001). OCT4 is down regulated during gastrulation and acts as an 
ESCs maintenance factor (Boiani and Schassler 2005) and it’s down regulation 
cause the loss of the pluripotent state (Nichols, Zevnik et al. 1998). In addition, 
OCT4 can be used in reprogramming somatic cells (Bortvin, Eggan et al. 
2003). OCT4 regulates the pluripotency state by the activation and the 
repression of hundreds of target genes (Boyer, Lee et al. 2005). (Abu-
Remaileh, Gerson et al. 2010) found that the fate decisions are regulated by the 
interaction between OCT4 and the Wnt/β-catenin signalling pathway (Abu-
Remaileh, Gerson et al. 2010).  
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1.10.4 FGF4  
FGFs consist of a large family of proteins. Those that interact with a family of 
receptors are designated (FGFG-1 to 4). The FGF4 gene was discovered firstly 
in human testicular germ cell tumours. It starts expression in early embryonic 
stages up to the pre-implementation blastocysts (Rappolee, Basilico et al. 
1994). FGF4 has an important role in embryogenesis as knock out FGF4 mice 
embryos die after implantation (Feldman, Poueymirou et al. 1995). FGF4 is 
expressed only in the primitive streak, and then in the tail bud (Kosaka, 
Sakamoto et al. 2009). Its expression is restricted in the ESCs and embryonic 
carcinoma (Kosaka, Sakamoto et al. 2009), and can be activated through 
SOX2/ OCT3-4 complex, which is important for development and 
pluripotency. Actually, OCT3-4 is an important regulator for FGF-4 
expression. FGF4 activates the Erk 1/2 signalling cascade in mouse ES 
(Kunath, Saba-El-Leil et al. 2007), while its inhibition does not affect ESCs 
proliferation (Kosaka, Sakamoto et al. 2009), but restricts ESCs ability to 
differentiate. The blockage of FGF-4-ERK signalling by the inhibitors 
(SU5402) and (PD184352), maintains ESCs self renewal (Ying, Wray et al. 
2008). In addition, in pre-implantation embryos, FGF4 inhibits trophectoderm 
differentiation in the placenta (Kosaka, Sakamoto et al. 2009). Therefore, FGF4 
maintains the pluripotency of ESCs and enhances self renewal of trophoblast 
stem cells (TSCs). 
   
1.10.5 CDX2 
CDX2 is a cell fate determining gene that plays an important role in 
trophectoderm specification (Nishioka, Yamamoto et al. 2008). CDX2 down 
regulates the expression of NANOG and OCT4 (Strumpf, Mao et al. 2005). At 
the blastocyst stage, CDX2 expression becomes restricted in the trophectoderm 
(TE) (Strumpf, Mao et al. 2005). It has been reported that CDX2 may be 
involved in allocation of blastomeres either at the ICM or TE, because CDX2 
expression is hetergenous in blastomeres at the 8- cell stage (Ralston and 
Rossant 2008). In addition, the level of CDX2 expression can affect cell 
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allocation as it can be detected in TE while not in the ICM. Thus, CDX2 early 
expression at the 8- cell stage embryo stage can influence polarity and therefore 
cell position. At the same time, the positioning of cells influences CDX2 
expression, later, in the 32- cell stage embryo (Jedrusik, Parfitt et al. 2008). 
 
1.10.6 SALL4 
Sall4 is an important transcription factor that maintains mESCs in the 
undifferentiated state through the binding and activation of the POU5f1 
promoter (Hamatani, Carter et al. 2004). Reduction of Sall4 induces ESCs 
differentiation to the trophectoderm cells (Jinqiu, Wai-Leong et al. 2006). 
Similar findings have been reported in vivo, as Sall4 reduction in pre-
implantation embryos causes a reduction in OCT4 expression and an increase 
CDX2 expression, the trophectoderm marker, in ICM cells. That suggested the 
importance of cooperation between OCT4 and Sall4 in early development. 
Also, Sall4 has an important role in regulating OCT4 activity in order to 
maintain ESCs in an undifferentiated state. 
 
1.10.7 KLF4 
KLFs are zinc finger containing transcription factors with different functions. 
Krupple-like factor 4 (KLF4) is highly expressed in epithelial tissues such as 
the gut and skin (Shields, Christy et al. 1996). Additionally, its expression has 
been detected in other tissues including testis, lung, lymphocytes and 
endothelial cells (Shields, Christy et al. 1996). KLF4 has many biological 
functions including cell cycle control, transcriptional regulation, apoptosis, 
differentiation and cell fate determination (Yusuf, Kharas et al. 2008). Knock 
out KLF4 mice were born with normal phenotype and histology (Katz, 
Perreault et al. 2002), but they die soon after birth, because of many 
complications including an inability to feed and the rapid loss of body fluid. 
KLF4 is a specific gene for goblet cell formation (Katz, Perreault et al. 2002). 
Thus, KLF4 is an essential factor in regulating many biologically functions. In 
addition, over expression of KLF4 inhibits cell proliferation in culture (Shields, 
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Christy et al. 1996). KLF4 involves in regulating ESCs self renewal (Li, 
McClintick et al. 2005), as KLF4 over expression has a great effects on ESCs 
self renewal. In addition, (Kim, Chu et al. 2008) reported that KLF4 has a 
crucial role in somatic cell reprogramming and ESCs self renewal maintenance 
(maintain immortality). KLF4 has been used in combination with other genes 
including OCT4, SOX2 and c-Myc in reprogramming somatic cells, as it 
cooperates with c-Myc to establish the immortal state of iPSCs. 
 
 
1.10.7 DPPA3 
Dppa3 is a gene expressed especially in oocytes, pre-implantation embryos and 
pluripotent cells (Sato, Kimura et al. 2002). Stella expression is activated 
during germ cell specification (Sato, Kimura et al. 2002). After the formation 
of the zygote, Dppa3 is expressed in the pro-nuclei until the blastocyst stage 
(Saitou, Barton et al. 2002). Then, Dppa3expression is down regulated until the 
formation of primordial germ cells (Saitou, Barton et al. 2002). (Payer, Saitou 
et al. 2003) found that the maternal inheritance of Dppa3 is important for 
embryonic development. Repression of Dppa3 from oocytes affects 
development and causes complications in blastocyst formation, implantation 
and poor development. In addition, Dppa3 transcription factor can bind to 
DNA and RNA in vitro (Payer, Saitou et al. 2003), suggesting that it might be 
involved in linking chromatin with RNA. Lack of Stella can affect other genes 
that are involved in development. The interaction between Dppa3 and NANOG 
can be associated with pluripotency, teratocarcinomas and germ cell tumours. 
 
1.11 In vitro production of embryos (IVP) 
The role of reproduction is fundamental to all life. Animal breeding, 
reproduction, selection and wild life conservation allow the maintenance and 
dissemination of species and breeds (Galli and Lazzari 2008). For example 
farm animal reproduction needs genetic selection to improve traits in the next 
generation (Galli and Lazzari 2008). Some of the technologies used are 
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genomics, proteomics and marker-assisted selection, which have become a 
necessity to improve traits. The improvement of assisted reproduction 
techniques in farm animals has increased our knowledge of the molecular 
mechanisms involved in reproductive systems. This has also improved our 
understanding of the roles played by male and female gametes and aspects of 
their fusion, the development of embryos, and lately the manipulation of early 
development embryos (Galli and Lazzari 2008). Therefore, reproductive 
technologies support an understanding of the biology related to reproduction. 
The technology that has had the greatest impact on animal breeding is in vitro 
production of embryos (IVP) (Galli and Lazzari 2008). IVP allows embryos to 
be obtained from infertile donors (Gordon 2003). IVP developed after the 
realisation that immature oocytes after in vitro maturation (IVM) can be used to 
produce viable embryos with high efficiency (Staigmiller and Moor 1984). The 
focus was on the female germline to overcome the physiological limitation to 
make better use of female gametes (oocytes) instead of wasting them by atresia 
(Galli and Lazzari 2008).  By this technique, the outcome of female gametes 
has greatly amplified. The first in vitro fertilised embryo was obtained in rabbit 
(Chang 1959). The mouse was the next mammalian species to be fertilised in 
vitro (Whittingham 1968). The first IVF calf derived from in vitro matured 
oocytes was in 1982 (Gordon 2003). Oocyte maturation and fertilisation 
techniques were developed by Lu and colleagues in 1987, and in1988 the first 
calves were born from a totally IVP system. Oocytes play the most crucial role 
in breeding (Staigmiller and Moor 1984). The production of a large proportion 
of good quality oocytes using in vitro techniques opened a new door in embryo 
production. The (IVP) of embryos  began with work on a number of 
approaches, such as, the control of meioses, in vitro fertilization (IVF), and 
embryo culture in vivo and in vitro. IVP first applied rodents in order to isolate 
and study the biology of intact follicles, and then grow them in culture (Gordon 
2003). In livestock this was a challenge because of the large size and 
connective tissue of the ovary. In 1992, Lazzari developed a protocol to isolate 
a large number of primordial oocytes from new born piglets’ ovaries, by 
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enzymatic digestion and centrifugal elution. This technique was improved by 
Miyano and Manabe 2007 by obtaining oocytes from secondary follicles. 
However, culture requirements to support the development of ovary follicles 
were complex. It was obvious that oocytes were present in secondary follicles 
of farm animals. More work was done to find the appropriate media for 
maturation in vitro. Successful results were obtained in bovine, in pig and in 
horse. IVM was better understood after applying IVF. Factors that affect the 
development of oocytes were identified such as, follicle size (Galli and Moor 
1991) and the interaction between oocytes and follicular cells (Staigmiller and 
Moor 1984). The retrieval of oocytes from live bovine donors, ovum pick up, 
(OPU) was a major step forward in developing an effective IVP system 
(Gordon 2003). In addition, IVF results were poor until heparin was used for 
sperm capacitation (Parrish, Susko-Parrish et al. 1986). Also, separation of X 
and Y sperm was obtained by flow cytometry to get embryos of the desired sex 
(Gordon 2003). However, there are number of concerns in producing embryos 
by IVP. For example, the low number of blastocysts obtained from every 
procedure, large offspring syndrome (LOS) (Young, Sinclair et al. 1998), and 
their lower ability to withstand freezing and thawing. Also, in vitro produced 
embryos have different molecular and cellular markers than those produced 
naturally (Gordon 2003). 
Still, IVP is a popular system, in 2005, as IETS reported 260,000 IVP embryos 
were transferred in farm animal because of its high yield of low cost embryos 
for transfer. These embryos were used for diagnosis, somatic cell and embryo 
cloning and for the production of transgenic cows, as well as for basic research 
on the mechanisms of embryogenesis (Gordon 2003). The IVP system is 
applied in most reproductive technology labs. The production of large numbers 
of embryos enables workers in the field to use them for research, which has a 
significant effect on the amount of knowledge related to oocyte maturation, 
fertilisation and the development of early embryos. Because of this knowledge 
in bovine and the similarities between the bovine and human early 
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development, the bovine model may replace the mouse model for early 
mammalian development (Wrenzycki, Herrmann et al. 2001).     
 
1.12 In vitro embryo production in cattle 
The cattle industry has a number of difficulties such as, cattle diseases and 
increased demand worldwide. These difficulties have reduced the outcome of 
cattle breeding, and have required the introduction of new techniques in order 
to produce embryos more efficiently and more cheaply. There are two major 
systems to produce cattle embryos, (MOET) for multiple ovulation embryo 
transfer and IVP for in vitro embryo production. The second system is used to 
produce embryonic stem cells, and will be focused on here. In this system, 
cattle embryos can be produced by using immature oocytes collected from the 
ovaries of donors of various age and physiological status. Following that, 
reliable procedures maintain these oocytes in vitro using a number of culture 
protocols to allow them to grow up to the stage suitable for transfer, freezing 
and culture. 
IVP comprises three different biological steps: in vitro maturation IVM, in 
vitro fertilization IVF, and in vitro culture IVC. 
1.13 Grading embryos 
In vitro produced mammalian embryos have differences in their characteristics 
in comparison to in vivo embryos. These characteristics include, lower cell 
numbers, an altered inner cell mass ICM: trophectoderm (TE) ratio, irregular 
size of blastomeres and cytoplasmic fragmentation, which lead to the reduction 
in developmental competence (Kruip and den Daas 1997). Cytoplasmic 
fragmentation is common in vivo and in vitro (Pereda, Cheviakoff et al. 1989; 
Alkani 1999). However, the degree of fragmentation can vary from a few 
fragments to extensive fragmentation. Apoptosis can happen naturally in in 
vivo-produced mammalian blastocysts (Byrne, Southgate et al. 1999), which 
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eliminates damaged or abnormal embryos (Hardy 1999). In addition, apoptosis 
is a major cause of embryonic arrest, in vitro, in bad culture conditions, such as 
an excess of embryo: media ratio, heat shock, excess of oxygen free radical 
concentrations, and exposure to a high concentration of spermatozoa during 
IVF (Tremoleda, Stout et al. 2003). The increasing use of blastocyst culture in 
an IVP system has encouraged the analysis of blastocyst parameters, and their 
effects on embryos death (Tremoleda, Stout et al. 2003). Parameters such as 
cell number and apoptosis rate can be indicators of the health and 
developmental potential of IVP produced embryos (Hardy 1999). But, to select 
good embryos the most common parameters are: the degree of fragmentation 
and the developmental stage. Extensive fragmentation can be associated with 
reduced blastocyst formation, and problems with implantation , despite that 
good quality embryos with no fragmentation can still be arrested (Hardy, Stark 
et al. 2003). 
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Total Grading 
15 (13) 1c,(4) 2c 
11 EB2, B2, B2, B2, TM3, 8c, TM2, 8c, XB2, XB1, B2 
11 XB2, B3, XB2, B2, B2, B2, 8c, 4c, XB2, XB2, B1 
11 XB2, TM2, TM2, XB3, B2, B1, XB2, 8c, B2, B1, XB3 
11 XB1, B2, HB2, B2, XB2, TM2, TM2, TM2, B2, XB1, B2 
12 (10) 1c, (2)2c 
10 EB2, XB2, XB1, B1, B2, XB1, TM2, B2, TM2, 8c 
11 EB1, EB2, XB1, XB2, TM2, TM1, B2, B1, XB2, B1, B3 
11 B1, B2, 8c, TM2, XB2, XB2, XB1, B2, TM1, B2, TM2 
10 B2, B2, B2, XB3, XB2, XB1, TM2, B3, TM2, TM1 
14 (11) 1c, (3) 2c 
10 XB2, EB2, dg, B3, B2, XB1, EB2, XB2, XB1, XB2 
11 XB1, XB2, B3, B2, B1, TM2, EB2, 6c, B1, B2,B3 
10 B1, B2, B1, XB2, B2, TM2, EB2, EB2, 4c, B3 
10 XB2, B2, B3, TM2, B1, B2, 8c, EB2, XB2, B2 
 
Table (1.2): Example of grading day 7 bovine embryos. c, cell, TM, tight 
morula, EB, early blastocyst, B, blastocyst, B1, blastocyst grade 1, B2, 
blastocyst grade 2, B3, blastocyst grade 3, XB, expanded blastocyst, HB, 
hatched blastocyst. 
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Chapter Two  
Materials and Methods 
 36 
 
2.1 In vitro production of bovine embryos 
2.1.1 Aspiration of ovaries 
An important factor in the maintenance of oocytes is temperature. It was 
important to avoid temperature shock and therefore the temperature must be 
monitored during the collection procedure. Ovaries were collected from the 
reproductive tract using scissors from slaughtered cows, and then placed in a 
warm saline solution in thermos flasks at the abattoir and brought to the 
aspiration lab within about 2-4 hours. Before aspiration was started the ovaries 
were washed three to four times in sterile 0.9% saline (30◦C) in another wide 
mouthed thermos flask to remove blood. Fifteen ml conical tubes were then 
filled with 2ml warm aspiration medium. 18 gauge needles were placed into the 
tubes and the blunt needle was then pushed into the second hole on the 
aspiration bung. The blunt needles were connected to a negative pressure (-45 
mmHg) from the aspiration machine. Follicles between 2-8 mm in diameter 
were aspirated. Tubes were filled up to three quarters, and then they were 
changed. From each ovary about 5 oocytes were expected. Full tubes were 
taken to the embryology lab to be analysed.  
 
Figure (2.1): Aspiration machine and tube warmer machine. Aspiration device was set 
on -40 to -45 mmHg and tube warmer was sat on 28˚C. 
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2.1.2 In vitro maturation (IVM) 
IVM plates were prepared in the morning (two hours before IVM) in a laminar 
flow hood. Six cm Petri dishes were used and 12 drops of 40 µl of maturation 
medium supplemented with cysteamine (Sigma) were placed using a dropper 
pipette. Drops were then overlaid with enough mineral oil to prevent 
evaporation. Plates were labelled with initials, date, and IVM, and placed in a 
5% CO2 incubator at 38.5. Ovaries were then aspirated as described previously. 
About 3ml of aspiration medium was added to a 9 cm plate, and the sediment, 
which was the oocytes aspirated and other cells, was added using a sterile glass 
Pasteur pipette with a syringe. The plate was then placed in a grid plate 
underneath a warm microscope stage. Cumulus-oocyte complexes (COCs) 
were searched for, and (COCs) that were light in colour with an even 
cytoplasm and surrounded by cumulus cells were selected, using a low volume 
pipettor and sterile pipette tips. Oocytes without cumulus cells or with a large 
number of cumulus cells layers were left behind, because they were either 
immature or too mature and this can lead to poor blastocyst development later. 
(COCs) were washed twice in 35mm Petri dish containing Hl99+ 10% FCS, 
and then washed in 35mm Petri dish containing Bl99+ 10% FCS. Ten (COCs) 
were then transferred to 40μl drops of IVM media, until all (COCs) were 
transferred. The time and the number of (COCs) in each plate were written on 
the Petri dish, before being placed into the 5% CO2 incubator for 22-24 hours 
at 38.5˚C. 
 
2.1.3 In vitro fertilisation (IVF): 
After 22-24 hours of oocyte maturation, they were then fertilised by the use of 
washed, frozen and thawed semen of a bull of known in vitro fertility (Dustin). 
IVF media is a synthetic oviduct fluid SOF medium, without glucose, with 
further addition of 10μg/ml heparin, 1μM pyruvate, and 1μM penicillamine 
(Sigma) and 2μM hypotaurine (Sigma) (IVF+ PPHH). The number of 
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spermatozoa that was needed was calculated after sperm counts using a 
haemocytometer. The required amount of IVF medium was added to the semen 
solution. 
 
2.1.3.1 Plate preparation 
Plates were prepared in a laminar flow hood. Chemicals were added to increase 
zygote development. 1μM Pyruvate was added to increase the developmental 
potential of the embryos, the 1μM penicillamine/ 2μM hypotaurine solution 
was added to maintain sperm motility, and heparin (1μl/ml) was added to 
capacitate the sperm and increase the chances of fertilization. Twelve drops of 
30μl and two 40μl drops for washing were placed in a 6 cm plates. Plates and 
IVF+ PPHH were placed in the 5%CO2 incubator at 38.5˚C for at least 2 hours 
to equilibrate. Also HSOF was placed into the incubator at 38.5˚C with the cap 
tightened to warm up.  
 
2.1.3.2 Sperm preparation  
Stock solutions and the percoll were warmed to room temperature before 
making the percoll solution to prevent precipitation. Sperm preparation was 
carried out in the laminar flow hood. Percoll gradients were prepared by 
pipetting 1ml of 45% percoll into a 15ml conical tube and carefully under 
laying it with 1 ml of 90% percoll solution. Warm water (~35˚C) was prepared 
in a beaker to thaw the semen straw. Straws were taken from the liquid 
nitrogen container and placed in the water beaker for 30 sec (one straw can 
fertilise 150 oocytes). One semen straw is 0.25 ml, and contained 
approximately 1×10
8
 spermatozoa/ml. Straws were dried and wiped with 70% 
ethanol to prevent contamination. The straw contents were placed into the tube 
by cutting the edges of the straw with sterile scissors. The tube with the percoll 
gradient/ sperm was centrifuged (Biofuge primo 75005181 centrifuge) at 700 g 
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(2200rpm) for at least 20 min. Sperm were recovered immediately when the 
centrifuge came to rest to prevent motile sperm from swimming up the 
gradient. Sperm were removed from the bottom of the tube using a sterile glass 
pipette with a syringe. The sperm pellet was then re-suspended in 1 ml of 
HSOF medium, and centrifuged again (Biofuge primo 75005181 centrifuge) at 
200g for 5 min. During this time 190μl of water was pipetted into a glass tube, 
and the Haemocytometer was prepared. The supernatant was then removed and 
the sperm pellet re-suspended in 200μl of equilibrated IVF+PPHH medium. A 
10μl aliquot of the solution was added to the 190μl of water to make a 1:20 
dilution. Using a pasture pipette and syringe the remaining volume of the 
solution was measured, and then placed in the CO2 incubator again at 38.5˚C to 
complete the sperm calculation. 
 
2.1.3.3 Sperm calculation 
The haemocytometer consisted of two grids; each one had 25 large squares 
with triple lines and 400 smaller squares, and a thick cover glass for an 
accurate count. The haemocytometer was prepared by placing a cover slip over 
the support shoulders. Seven to10μl of the 1 in 20 sperm dilution was placed in 
the both edges of the cover slip, by touching the edge and the cover slip and 
allowed the sample to flow under the cover slip. The sperm were counted in the 
25large squares under the microscope on (x20). Only spermatozoa whose head 
was within the triple lines were counted. Both grids were counted and then the 
mean of the two was used to calculate the final concentration of 1 million 
sperm/ ml, using this formula: 
(Volume measured (A) × Average number of sperm count (B))  ÷ 25 =Total 
volume (C). 
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The total volume (C) – Volume measured (A) = Volume of IVF+ PPHH 
medium to add (D) to sperm dilution. 
 
When dealing with sperm, the dilution medium was added gently and slowly so 
the sperm to prevent dilution shock. Also, the diluted sperm were kept in the 
CO2 incubator during the calculation period to keep the pH and the temperature 
at the optimal level. After the calculation was done and the medium was added, 
10μl of diluted sperm was added to each drop containing oocytes. IVF drops 
were checked to ensure sperm motility. IVF plates were placed in the CO2 
incubator for 18-24 hours at 38.5˚C. 
 
2.1.3.4 Oocyte preparation 
During sperm centrifugation, oocytes were prepared, by removing them from 
IVM drops using a large volume pipettor and transferring them to a 35mm Petri 
dish containing HSOF. Cumulus cells were removed by pipetting the 
complexes up and down many times until most the cumulus cells were 
removed. Oocytes were then transferred to another HSOF dish, then to an 
IVF+PPHH plate. Five oocytes in 10μl of IVF+PPHH were placed in IVF 
drops, and then plates were placed again in the 5% CO2 incubator at 38.5˚C. 
 
2.1.4 In vitro culture (IVC) 
18-24 hours after fertilisation of oocytes, the cumulus was removed and 
presumptive embryos were placed in culture in a modular incubator chamber 
for 5 days. The day of fertilisation was day 0, and the first day in culture was 
day 1. Medium was changed on day 5 and plates were placed in a modular 
incubator chamber for 2 days. Embryo development was scored on day 7. For 
example if IVM was done on Monday, IVC would be done on Wednesday, 
changeover would be on Sunday, and embryos development would be on 
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Tuesday. Plates for IVC were prepared in the laminar flow hood. Five drops of 
20μl early SOF and 2 of 40μl of washing drops were placed in 35mm plate. 
Drops were covered with mineral oil. Plates were placed in a modular 
incubator chamber, and gas was turned on (5%CO2, 7%O2 and 88%N2) for 5 
min. Modular incubator clumps were closed to keep the gas in, and it was 
placed in a dry incubator at 38.5˚C for two hours for equilibration of the plates. 
The modular incubator chamber was prepared by placing a small amount of 
sterile water in the 60 mm plate (only the bottom side of the plate) to humidify 
the chamber. A 35mm plate of BI99+ FCS was placed in the chamber as an 
indicator (it should remain salmon pink colour) to ensure that the chamber was 
gassed. The black o-ring was greased with lubricant, the lid of the modular 
incubator was placed, and clamps were closed. Embryos were pulled using a 
pipette and cumulus was removed in the washing drops of IVF by pipetting up 
and down several times. Embryos then were transferred to a 35mm plate of 
warm HSOF to be washed; this step was repeated for two or three times. Using 
a mouth pipette, embryos were placed in the first washing drop of ESOF then 
to the second. 10-15 embryos were placed in each culture drop. Each plate was 
marked with the number of embryos, and placed in the chamber. After 
processing all of the plates, they were placed in the chamber to be gassed for 5 
minutes (5%CO2, 7%O2 and 88%N2). The closed chamber was then placed in 
the dry incubator for 5 days at 38.5˚C. On day 5 embryos were removed from 
ESOF medium by mouth pipette to late synthetic oviduct medium (LSOF) 
plates that were prepared with the same ESOF plates. Plates were returned to 
the chamber and gassed (5%CO2, 7%O2 and 88%N2). Chamber was placed in 
the dry incubator at 38.5˚C for more two days. On day 7 embryos were graded.  
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2.2 Grading embryos 
Day 7embryos were graded depending on the degree of fragmentation and the 
stage of development, using the criteria described. 
2.3 Single blastomere culture in different substrates 
2.3.1 Coating plates 
96 well plates were used (Nunclon, Lot no. 105851). The number of wells that 
were used for every substrate was determined depending on the experiment. 
Substrates varied in some experiments depending on their availability and the 
plan of the experiment. Coating the 96-well plates or other types of plates was 
done in the laminar flow. On the lid, the date of the experiment, my initials, the 
media used in the experiment including additives and the substrates used with 
lines to illustrate their place in the plate, were written. Fifty μl of each substrate 
was added to every well in the 96-well plate. With the lid on, plates were put in 
the CO2 incubator at 38.5 C for 30 minutes to dry. Excess coating was tipped 
out, and 100μl PBS (Sigma) was added to every well for washing. Plates were 
left to dry for another 30 min with the lid off in the laminar flow. Then, 100 µl 
of ESOF was added to every coated well. In case of using 2i or 3i media, 
supplements were added to the ESOF media including CHIR 99021(Biovision), 
PD0325901 (Stemgent) and PD173074. Plates were gassed using triple gas in 
the incubator chamber, and left over night. It is important not to coat all the 
wells in the 96-well plates, as the loading of blastomeres takes time, which may 
affect the pH of the media.  
2.4 Immunosurgery 
THSOF-BSA (20µl 50 X Essential amino acid/ml + 10µl Non- essential amino 
acid) was placed in the 38.5˚C CO2 incubator to warm up before use it in the 
procedure. Anti bovine serum developed in rabbit (RαB) (Sigma) and Guinea 
pig compliment serum (GP) (Sigma) working solutions were prepared by the 
addition of 150µl THSOF-BSA to a 50µl RαB aliquot and centrifuging for 5 
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min at 2000 rpm before the use. GP was prepared by the same way. 40µl 
droplets for washing and 20µl for incubation were made in 6cm for both RαB 
and GB. Drops were covered with mineral oil and plates were placed on the 
warm stage. Zona pellucid was removed from the selected blastocysts by 
placing them in pronase drops. Blastocysts were washed in THSOF-BSA to 
stop pronase activity, this step was repeated three times. 5 blastocysts were 
placed at a time in the washing drop of RαB then to other washing drops to 
remove THSOF-BSA. Then they were placed in 20µl drop for 45 min in the 
CO2 incubator at 38˚C. During this time antibodies were bind to the TE cells. 
After 45 min blastocysts were removed from RαB drops and washed in 
THSOF-BSA plates. Again 5 blastocysts were placed in the washing drop of 
GP then in the incubation drop. Blastocysts were left for 45 min in the CO2 
incubator at 38˚C. During this time finely drawn Pasteur pipette were made. 
After incubation, blastocysts with lysed TE cells were placed in THSOF-BSA 
and by the pipette TE cells were dislodge from the ICM cells. ICMs were then 
placed in the pre-coated wells and placed in the chamber to be gassed (5%CO2, 
7%O2 and 88%N2).        
2.5 Dissociation method 
Before starting, the required stage of embryonic development was selected with 
the emphasis placed on the quality of embryos selected. The zona pellucida 
was removed from the embryos by placing 30 embryos in 50μl drops of 0.5% 
pronase in HSOF –BSA+Ca+Mg 1mg/ml of PVA (sigma P811 lot 016k1523). 
When the zona pellucida began to lose shape, embryos were transferred to 
HSOF in 35mm plate to be washed twice. 
Nine ×30 μl HSOF drops were placed in 60mm Petri dish, covered with 
mineral oil and left on the warm stage to warm up. Zona free embryos were 
placed in these drops to be dissociated using a pooled mouth pipette. The size 
of mouth pipette is important; it needs to be slightly larger than embryos to 
ease the dissociation procedure. The embryos were dissociated by lifting them 
up and down in the mouth pipette. After embryos were dissociated, the 
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microscope was placed in the lamina flow hood, and the transfer was done in 
the hood to avoid contamination. A single blastomere, a group of blastomeres, 
a zona free whole embryo, or a zona intact whole embryo was placed in the 
wells following the experimental plan. Ninety-six well plates were placed in 
the incubator chamber to be gassed, and left for 5 days. 
On day 5 the plates were graded, and wells with outgrowth were marked. On 
day 7, 100 μl of N2B27 (invitrogen) + 20% FCS was added to each well with 
an outgrowth. All procedures related to 96-well plates were done in the hood to 
avoid contamination.     
 
2.6 Blastomere culture using dimples 
In the previous blastomere culture experiments there was a poor outcome 
associated with a low number of blastomeres. The goal of these set of 
experiments was to obtain embryonic stem cells from a single blastomere. 
The separation of blastomeres of embryos at the eight cell stage was applied at 
day two of culture. The zone pellucida was removed by the exposure of the 
embryos to 0.5% pronase in HSOF –BSA+Ca+Mg 1mg/ml of PVA (sigma 
P811 lot 016k1523). About 30 embryos were loaded into 50 µl drops of 
pronase, and left for 1-2 min or until the zone pellucida was removed. Embryos 
were then transferred to 35mm HSOF plate to be washed. Then, each embryo 
was placed in 30 µl drops of dissociation media (HSOF-Ca+3mg/ml 
BSA+0.02% EDTA+ 5µg/ml CB) and gentle pipetting with a pooled "tapered" 
pasteur pipette was performed. Then, blastomeres were placed in HSOF drops 
to be washed. Then, dissociated blastomeres were transferred to plates with 
dimples using a very fine pooled pasture pipette (slightly larger than a 
blastomere size). The number of blastomeres in each dimple depends on the 
experimental  plan. Plates were placed in the modular chamber under a gas 
phase of (CO2 5%, O2 7%, and N2 88%) with humidity at 38.5C° in the dry 
incubator to be gassed, and then left in the dry incubator at 38.5˚C. These 
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procedures were conducted on a warm stage (36-38˚C) and at room 
temperature (24-26˚C). 
 
2.6.1 Preparing dimples 
Conical wells or dimples were prepared on the bottom of a 60 mm culture dish. 
One, 3, 6 and 12 conical wells were created in groups by pressing the bottom of 
the dish using a sterile (rod). Each group of micro wells was covered with 20µl 
drop of 0.1% gelatin, then left to dry, with the lid on. Embryonic stem cell 
culture medium then was covered with mineral oil. Plates were left to 
equilibrate for 2 hr under a gas phase of (CO2 5%, O2 7%, and N2 88%) with 
humidity at 38.5C° in the modular chamber in the incubator, before 
blastomeres were placed. 
 
2.6.2 Single blastomere culture in different substrates using tissue 
culture plates 
60 mm tissue culture plates (Falcon, U.S.A) were used for the experiment. 
20×5μl drops of every substrate (collagen, gelatin, poly-lysine, fibronectin) 
were placed in each plate. Drops were left to dry in the laminar flow. Access of 
substrates was removed using a mouth pipette, Five μl ESOF drops were 
placed in place of the substrates drops. Drops were covered with mineral oil, 
and left in the modular chamber to equilibrate. The same dissociation method 
was followed. In case of using 32 cell stage embryos, dissociation media 
(HSOF-Ca+3mg/ml BSA+0.02% EDTA+ 5µg/ml CB) was used to dissociate 
embryos. 
 
 
 
 46 
 
2.7 Counting cells in bovine outgrowth derived from dissociated 
blastomeres 
Cell culture media (DMEM/F12+ 10% FCS) and trypsin (0.05% / 1mm EDTA) 
were placed in the incubator to be warmed. Wells with outgrowths were 
marked and ES media was aspirated off the outgrowths. Outgrowths were then 
washed with an appropriate volume of warm PBS. Enough trypsin (0.25%/ 
1mm EDTA) to cover the outgrowths was added to each well. The plate was 
left in the incubator for 6-10 min. Then, cells were pipetted up and down using 
a plugged Pasteur pipette to break the outgrowths. The plate was returned into 
the incubator for another 6 min, and then outgrowths and the enzyme were 
pipetted to get single cells. Then each outgrowth was transferred to a 15ml 
conical tube and the enzyme activity was blocked by the addition of warm 
culture media (DMEM/F12+10% FCS). Tubes were spun for 3min at 1000 
rpm. Supernatant was aspirated off and the pellet was resuspended in an 
appropriate amount of ES culture media. Ten µl of the solution was loaded in 
the haemocytometer for counting. Then the solution was transferred into 4 well 
tissue culture plates to reattach. In the haemocytometer there was 5 large 
squares, only shiny cells were counted in those. The total number of cells in 
each outgrowth was calculated using the following equation: 
(no. of cells counted ÷ no. of squares) x volume (ml) x 10,000 
 
2.8 Passage bovine outgrowth derived from dissociated blastomeres 
2.8.1 Mechanical passaging 
When the outgrowth filled the well it was passaged and transferred to a larger 
well to let the outgrowth extend its proliferation. Before the passage, the new 
plate was prepared with coating substrate and the media as mentioned before 
and left in the CO2 incubator at 38.5˚C to equilibrate. To passage the 
outgrowth, sterile needles were used to cut the outgrowth into parts, and then 
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these pieces were transferred using a pipette to the new well with the fresh 
media. After passaging all the outgrowths, the new plate was placed in the 
modular chamber to be gassed with the triple gas, and then left in the dry 
incubator at 38.5˚C. 
 
2.8.2 Enzymatic passaging 
To dissociate bovine outgrowths, trypsin (0.25%) (Gibco), Accutase (Gibco), 
dispase (0.5 mg/ml) Gibco and type IV collagenase (Gibco) were used. The 
enzyme was added to the outgrowth and then left in the CO2 incubator for 5 
min. The outgrowth was lifted up and easy to be transferred to gelatin 0.1% 
pre-coated plate. The plate was placed in the modular chamber to be gassed 
with the triple gas.   
2.9 KARYOTYPING: 
Nocodozole (0.1µg/ml) was added the night before karyotyping (1:2000). This 
is recommended for counting, as it shortens the chromosomes and gives a more 
accurate count. DMEM was in the CO2 incubator for 10-15 min to be warm 
prior the use. The medium was aspirated, and then trypsin was added to the 
wells with outgrowths and left in the incubator for 1-2 min. Trypsin activity 
was blocked with DMEM media. Outgrowths with the media were spun for 3 
min at 1000 rpm. The supernatant was aspirated, and about 5ml of 0.56% KCl 
was added to the sediment with the little media and then, incubated for 30 min 
in the water bath at 37˚C. Five ml of KCl from the freezer was added slowly to 
the side of the tube. The tube was spun for 3 min at 1000 rpm, and the 
supernatant was aspirated. Five ml of KCl from the freezer was added slowly 
without pipetting. The tube was incubated in the fridge for 30 min. The last two 
steps were repeated twice. Then about 100µl of ice cold KCl was added, and 
the solution was pipetted up and down until it was cloudy. The solution was 
returned to the fridge until Pasteur pipettes were made, and slides prepared. 
Using the Pasteur pipette, 3 drops of the cell solutions were made in each slide 
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by holding the Pasteur pipette vertically on the slide. Slides were left to dry, 
and then labelled. Slides were stained using 5% Giemsa stain for 20 min, and 
then washed using tap water.           
 
2.9.1 Slide preparation 
Clean microscope slides with a frosted end were used. Slides were wiped with 
70% ethanol, and then they were placed into a vertical slide holder and put into 
a -20 freezer for 2-3 min. 
 
2.9.2 Slide staining 
Gurr buffer was prepared by dissolving 1 Gurr buffer tablet in 100 ml of MQ 
H2O. Giemsa stain was prepared by adding 2.5 ml of giemsa stock solution to 
47.5 ml of Gurr buffer (PH6.8). Slides can be stained at the same day of 
counting chromosomes if spreads are dry. Gloves must be worn when putting 
slides into the staining solution. Slides were placed into Giemsa stain for 20-25 
min, and then they were washed carefully and gently with tap water. Slides 
were left to dry vertically, and then they were ready for examination under the 
microscope. 
 
2.10 Nucleic Acid Manipulation 
2.10.1 Total RNA isolation 
Gloves were worn at all times in the molecular lab, and work space and 
pipettes were wiped with ethanol before starting. All steps were carried out on 
ice. Each sample was given a code number to distinguish it from others. 
Samples were kept in Trizol (Invitrogen, NZ) in -20 freezer. One µl of 
ms2RNA (200 ng/ µl) (Invitrogen, NZ), a carrier, and 5µl alpha globin (1pg/µl) 
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(Sigma) was added to make the RNA visual and sticks to the side on the tube to 
prevent the loss of RNA from the sample, and then they were mixed by 
pipetting. An appropriate amount of ice cold chloroform CHCl3 was added (1:5 
ratio), and then spun at 7000 rpm (Biofuge fresco 75005521centrifuge) at 4˚C 
for 10 min. In empty tubes 4µl of liner poly acrylamide (5 µg/ ml) was added, 
which help to sterile the precipitate, while waiting for the centrifuge to stop. 
The top layer (aqueous phase) was transferred carefully to the tube with linear 
polyacrylamide, and then an equal volume of isopropanol was added, which 
binds to the RNA and makes it precipitate. Tubes were incubated for 10 min at 
room temperature, and then spun for 30 min at 13000 rpm (Biofuge fresco 
75005521centrifuge) at 4˚C orientated tubes to make it easier to locate the 
pellet. Supernatants were decanted by aspiration carefully, and then 70% 
ethanol was added for washing. Tubes were spun at 13000 rpm (Biofuge fresco 
75005521centrifuge) for 10 min (orientated tubes), and then supernatants were 
decanted again. The pellets were allowed to dry at 95˚C for 2 min, and then 
they were re-suspended in ~ 8 µl of DEPC water, and then centrifuged 
(Eppendorf Minispin plus 5453). Tubes were incubated at 65˚C for 2 min in the 
PCR machine, and then kept at 4˚C for 10 min to redissolve before putting on 
ice for 30 min. 
 
2.10.2 Dnase treatment 
One µl of 10X Dnase buffer (1ml) (Invitrogen, NZ) and 2 µl of Dnase I (1U/μl) 
were added, and then spun down (Biofuge fresco 75005521centrifuge). Tubes 
were incubated for 60 min at 37˚C in the PCR machine. EDTA (25 mM, 
Invitrogen, NZ) was added to stop the Dnase reaction, and then tubes were 
incubated at 65˚C for 10 min. Ten µl of Sodium Acetate NaOAc and 100% 
ethanol were added, and then tubes were left in -80 freezer for an hour. Then 
after freezing, samples were centrifuged at 13000 rpm (Biofuge fresco 
75005521centrifuge) for 30 min at 4˚C, and then aspirated to remove the 
supernatants. Ethanol was used to wash the pellet, and then the tubes were 
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centrifuged for 10 min at 13000 rpm (Biofuge fresco 75005521centrifuge). 
Ethanol was aspirated and then the samples were allowed to dry. The samples 
were re-suspended in 11 µl of DEPC water and then vortexed, and then re-
dissolved by incubating foe 2 min at 90˚C. Samples were left on ice for 2 min. 
 
2.10.3 cDNA synthesis 
One µl of both Random hexamers (Invitrogen, NZ) and dNTP mix (10mM, 
Invetrogen, NZ) were added on ice, and then incubated for 5 min at 65˚C. 
Samples were left on ice for 1 min, and then spun down in the mini centrifuge 
(Eppendrof Mini plus 5453). Master Mix was added to every RNA sample (2 
µl 10X First strand buffer, 4 µl MgCl2 (25mM), 1 µl RNase OUT, and 1 µl 
Superscript III, not added to the RT control, Invitrogen, NZ). Then, samples 
were vortexed and then 10µl of master mix was added to 13 µl of RNA/ buffer, 
and then incubated for 10 min at 25˚C, then at 85˚C for 5 min. Samples then 
were placed in a -20 freezer to chill. One µl of RNase H (Invitrogen,NZ) was 
added, and then samples were incubated at 37˚C for 20 min. The RT control is 
mRNA that has not been transcribed to cDNA, which helps to find out any 
DNA contamination and should not be amplified in the PCR.  
 
2.10.4 RT- PCR 
Before starting the PCR, samples were vortexed and centrifuged shortly 
(Eppendrof minispin plus 5453) and all pipettes and work area were wiped with 
ethanol, before use. For each PCR run a positive control (group of blastocysts) 
and H2O (no cDNA sample just DEPC water) were included in the analysis. 
Master mix was prepared by adding (20.8µl of DEPC,  2.5 µl of 10X buffer + 
MgCl2, 0.5 µl of dNTPs (10 mM), 1.0 µl of F+R primer and finally 0.2 µl of 
Taq, all from Invitrogen, NZ). Not, the volumes are per sample, if 10 samples 
were to be run, the volume was multiply by 10. Twenty-five µl was added to 1 
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µl of the cDNA sample to be run, and then samples with master mix were 
placed in the PCR machine Light Cycler®, by putting the capillaries in the 
wells. Capillaries must be locked and pushed down, before locking the lid. The 
soft ware was prepared prior to carrying out the run, with the appropriate 
annealing temperature. PCR should be run as quickly as possible. The machine 
was run at 95˚C for 5 min for polymerase activation, followed by 35 cycles for 
denaturation at 95˚C for 30 sec, annealing at the appropriate temperature for 30 
sec, then elongation at 72˚C for 30 sec in each cycle, and  then at 72˚C for 5 
min. Capillaries were frozen at -4˚C following the run in order to load the 
samples later into to the gel. 
 
2.10.5 Agarose gel electrophoresis 
The gel was prepared using 1% agarose (Invitrogen, NZ) with TAE buffer (2M 
Tris, 250 mM Glacial Acetic Acid, 50mM EDTA+ 1L H2O). Super safe gel 
stain (10000X in DMSO) (Invitrogen, NZ) was added to the gel before loading 
the warm gel into the clean appropriate size box to contain the gel. Clean tape 
was placed in both sides of the box to keep the gel inside the box. The comb 
was placed at one end of the gel insert to place the PCR samples later. The gel 
was poured into the gel box and left to set for 30 min. Bromo-methylene dye 
solution was added to the samples to make them sink. The gel tray was placed 
into the machine, with the care that the comb ends at the negative electrode. 
The reservoir was filled to just under the maximum mark and covered the gel 
with 0.5% TAE buffer. The comb was removed carefully, and then each 
sample (15µl) was loaded in order along the wells following the template of the 
samples. Between each load, the tip of the pipette was washed in the TAE 
buffer to avoid contamination between samples. At the end 5µl of the marker 
was loaded, 1KB plus DNA ladder (Invitrogen, NZ) to check the fragment size 
later. The lid was placed on the reservoir and the machine was turned on. For 
small gels the sitting was placed on low 80-90 volts and for larger gels it was 
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130 volts. The machine was turned off when the blue line was at the end of the 
gel, and then the gel was lifted out the machine in a paper towel. 
2.10.6 Reading the gel 
The gel was placed inside a gel-reader, and the computer was turned on using 
the (Quality One) programme, File: gel.doc. The visible light was turned on 
and the image was focused to insure that the wells can be seen clearly. Visible 
light was turned off, and then the UV was turned on. By using the live focus 
button and adjusting the intensity of light, the image can be visualised. Image 
was printed and saved for analysis.    
           2.10.7 NANOG (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for NANOG were: 
Forward primer: CACCCATGCCTGAAGAAAGT 
Reverse primer: TGCATTTGCTGGAGACTGAG 
Annealing temperature: 56˚C 
Fragment size: 438 bp 
 
2.10.8 OCT4 (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for OCT4 were:  
Forward primer: GGTTCTCTTTGGAAAGGTGTTC 
Reverse primer: TGGCGACGGTTGCAAAACCA 
Annealing temperature: 56˚C 
Fragment size: 333 bp 
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2.10.9 Sox2 (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Sox2 were: 
Forward primer: CTA TGA CCA GCT CGC AGA 
Reverse primer: GGA AGA AGA GGT AAC CAC G 
Annealing temperature: 58˚C 
Fragment size: 152 bp 
 
2.10.10Klf4 (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Klf4 were: 
Forward primer: TCCCACCGCTCCATTAC 
Reverse primer: ATGAGAACTCTTCGTGTAGG 
Annealing temperature: 60˚C 
Fragment size: 158bp 
 
2.10.11 Dppa3 (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Dppa3 were: 
Forward primer: TCT TAC CCC TCT CCG CCT AT 
Reverse primer: TGC AAG TTG CCA CTC AAC TC 
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Annealing temperature: 55˚C 
Fragment size: 296 bp 
 
2.10.12 Sall4 (Invitrogen) mRNA analysis: 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Sall4 were: 
Forward primer: CGG GTG CTC CAA TGA ACT AT 
Reverse primer: TGT CCT TCA AGA TGA GCA CG 
Annealing temperature: 55˚C 
Fragment size: 195bp 
 
2.10.13 β-actin (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for β-actin were: 
Forward primer: GGCATCCTGACCCTCAAGTA 
Reverse primer: CACACGGACCTCGTTGTAGA 
Annealing temperature: 52˚C 
Fragment size: 100bp 
 
2.10.14 Lefty1 (Invitrogen) mRNA analysis 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Lefty were: 
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Forward primer: CAG GGA CTA TGG AGC TCA GG 
Reverse primer: CTG GAT GCT GAC AAT CAT GG 
Annealing temperature: 55˚C 
Fragment size: 268bp 
 
2.10.15 FGF4 (Invitrogen) mRNA analysis: 
PCR analysis was carried out according to the RT-PCR method. The primers 
for FGF4 were: 
Forward primer: GCGACTTCCTCTTCTTCCC 
Reverse primer: GCAGATGGAAACCGATGC 
Annealing temperature: 55˚C 
Fragment size: 151bp 
 
2.10.16 Cdx2 (Invitrogen) mRNA analysis: 
PCR analysis was carried out according to the RT-PCR method. The primers 
for Cdx2 were: 
Forward primer: AGACAAATACCGGGTCGTGTACA 
Reverse primer: TTTGCTCTGCGGTTCTGAA 
Annealing temperature: 60˚C 
Fragment size: 162 bp. 
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Primer 
Forward/ 
Revese source Primers sequence 
Annealing 
temperature 
Fragment 
size 
Cdx2 F bovine AGACAAATACCGGGTCGTGTACA  60°C  162 
Cdx2 R bovine TTTGCTCTGCGGTTCTGAA     
Dppa3 R bovine TCT TAC CCC TCT CCG CCT AT  55°C  158 
Dppa3 F bovine TGC AAG TTG CCA CTC AAC TC 
  Fgf5.2 F bovine GCGACTTCCTCTTCTTCCC 55°C 151 
Fgf5.2 R bovine GCAGATGGAAACCGATGC     
Klf4  F bovine TCCCACCGCTCCATTAC  60°C  158 
Klf4  R bovine ATGAGAACTCTTCGTGTAGG     
Lefty 1 F bovine CAG GGA CTA TGG AGC TCA GG 55°C 268 
Lefty 1 R bovine CTG GAT GCT GAC AAT CAT GG     
Nanog F bovine CACCCATGCCTGAAGAAAGT 56°C 438/295 
Nanog R bovine TGCATTTGCTGGAGACTGAG     
Oct 4 F bovine GGTTCTCTTTGGAAAGGTGTTC 60°C 333 
Oct 4 R bovine TGGCGACGGTTGCAAAACCA     
Sall4 F bovine CGG GTG CTC CAA TGA ACT AT 55°C 195 
Sall4 R bovine TGT CCT TCA AGA TGA GCA CG     
Sox2  F bovine CTA TGA CCA GCT CGC AGA 60°C 152 
Sox2  R bovine GGA AGA AGA GGT AAC CAC G     
β-
Actin F  bovine GGCATCCTGACCCTCAAGTA  52°C 100  
β-
Actin R  bovine CACACGGACCTCGTTGTAGA 
   
Table (2.1): The primers used in PCR, their reverse and forward primers, annealing 
temperature and fragment size. Bovine mRNA sequences were obtained from the 
AgResearch-DNA sequence database and primers were designed by invitrogen. 
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2.11 Statistical analysis 
All values are presented as a mean ± SD, unless indicated otherwise. Statistical 
significance was accepted at P < 0.05 and determined using the two-tailed 
Fisher-test in 2x2 tables or two-taled t-test with unequal variance). 
 
2.12: Reagents, solutions and media composition 
Embryonic stem cell media: 
78% DMEM/F12 base media (Global Science and Technology) Cat# BR014G 
with 20% FCS(Gibco) Cat# 10091-148  and fresh 1% mercaptoethanol (Sigma) 
and 1% non essential amino acids (Sigma). 
 
B199: 
Bicarbonate buffered medium M199 with 1mM glutamine and 0.2mM pyruvate 
with antibiotics: kanamycin sulphate from streptomyces K1377-25G with stock 
B: 10ml of sodium bicarbonate S5 761-500G (Sigma) and stock C: .06ml of 
sodium pyruvate P1562-100G. 
 
IVM medium: 
IVM medium containes: B199, FCS, stock FSH, LH. B199 (base 
medium)+10% FCS (foetal calf serum) (Life Technology) with 10µg/ml ovine 
follicle-stimulating hormone (FSH) (Ovagen; Immuno- Chemical Products 
[ICP], Auckland, New Zealand), 1µg/ml ovine lutanizing hormone (LH) (ICP), 
1 µg/ml β-estradiol E2758-1G in absolute ethanol E/0650DF/17 (Fisher 
Scientific) and 10µl/ml cysteamine just prior to use. 
HSOF: 
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Hepes-buffered synthetic oviduct fluid (SOF) with 107.7 mM NaCl, 7.15 mM 
KCl, 0.3mM KH2PO4, 5mM NaHCO3, 3.32 mM sodium lactate, 0.069 mM 
kanamycin monosulfate, 20 mM Hepes, 0.33 mM pyruvate, 1.71 mM CaCl2. 
2H2O, 3mg/ml fatty-acid free bovine albumin (ABIVP; ICP) (Thompson et. al., 
1990)  
 
Aspiration media: 
H199+925 IU/ml Heparin (CP Pharmaceuticals Ltd., UK) + 20% (w/v) 
Albumin concentrate (ICP). 
 
IVF SOF medium: 
107.7 mM Nacl, 7015 mM KCl, 0.3 mM KH2PO4, 25 mM NAHCO3, 3.32 
mM sodium lactate, 1.71 mM CaCl2.2H2O, 0.04 mM kanamycin monosulfate, 
8 mg/ml fatty-acid free bovine albumin (ABIVP, ICPbio), supplemented with 
0.33 mM sodium pyruvate, 0.001 mM Heparin, 0.2 mM penicillamine and 0.1 
mM hypotaurine. 
 
Redigrad™  
Composition: Silica sol with cavalently linked saline 
Density (g/ml): 1.130 ± 0.005 
Osmolarity (mOsm/kg H2O): max. 30 
Viscosity (cP): max. 15 at 20˚C 
PH: 9.4  ± 0.5 at 20 ˚C to 25˚C 
Endotoxin (EU/ ml): max. 2 
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GE Healthcare Life Science, Level 1, 8 Tangihua Street, Auckland 1010, New 
Zealand. 
 
Biphasic AgR SOF (ESOF): 
Biphasic AgResearch Synthetic Oviduct Fluid medium (AgR SOF, 
AgResearch, Hamilton, New Zealand). AgR SOF is modified formulation it 
contains:107.7 mM NaCl, 316 mM KCl, 100x 90 mM KH2PO4, 1.32g/ml 
60%wv C3H5O3Na, C18H36N4O11H2SO4, 25 mM NAHCO3, 33mM C3H3O3Na, 
171mM CaCl2 2H20, 49mM MgCl2 6H2O, 316 mM KCl, 60mM C6H12O6 and 
Non Essential Amino Acid 100x, Gluta-Max 1 and (BSA). 
 
Biphasic AgR SOF (LSOF): 
LSOF contains: 107.7 mM NaCl, 316 mM KCl, 100x 90 mM KH2PO4, 
1.32g/ml 60%wv C3H5O3Na, C18H36N4O11H2SO4, 25 mM NAHCO3, 33mM 
C3H3O3Na, 171mM CaCl2 2H20, 49mM MgCl2 6H2O, 60mM C6H12O6 and 
Non Essential Amino Acid 100x, Gluta-Max 1, BM Essential Amino Acid and 
(BSA). 
 
Phosphate-buffer saline (PBS): 
1.9 mM/l sodium dihydrogen orthophosphate 1-hydrate, 8.4 mM/l disodium 
hydrogen orthophosphate 2-hydrate and 150 mM/l sodium chloride. 
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concentration Code Chemicals Chemicals Formula 
171 mM A Calccium Chloride 2 hydrate  Ca Cl2 2H2O 
60 mM D D-(+)-Glucose C6 H12 O6 
250 mM E Hepesfree acid C8 H17 N2 O4 S 
250 mM F Hepes Sodium salt  C8 H17 N2 O4 Sna 
1MU G Heparin Sodium salt 1,000,000   
100 MG H Hypotaurine C2 H7 NO2 Sna 
  I Kanamycin Monosulphate C18 H36 N4 O11 H2SO4 
49 mM K Magnesium Choloride Mg Cl2 6H2O 
316 mM O Potassium Chloride KCl 
100x 90 mM P Potasium Phosphate mono-basic KH2 PO4 
33 mM S Pyruvic acid C3H3O3 Na 
250 mM Q Sodium Bicarbonate Na HCO3 
107.7mM U Sodium Chloride Na Cl 
 1.32g/ml 
60%wv X DL-Lactate Acid  C3 H5 O3 Na 
 
Table (2.2): The chemicals used in the different media, their concentration, 
code and their formula. 
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Chemical number 
and company  code  chemicals  
17-5445-01 
(Healthcare) 1 Percoll Plus 
M-7145 (sigma) 2 
Non-Essential Amino 
Acid 100x 
B6766 (sigma) 3 
BM Essential Amino 
Acid 50x 
35050 (GIBCO) 4 Gluta- Max 1 
H-3149 (Sigma) 5 Heparin 5,000 1μ/ml 
30044-333 
(GIBCO) 6 
Fetal Bovine Serum 
(FCS) 
30036-578 
(GIBCO) 7 
Albumin Concentrate 
(BSA) 
M6500-25G 
(Sigma) 8 Cysteamine  
P4875-25G 
(Sigma) 9 Penicillimine 
H1384-1G (Sigma) 10 Hypotaurine 
 
Table (2.3): The chemicals used, the company they were obtained from and their code 
number. 
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medium chemicals code 
HSOF UOPXIQEFSA7 
IVF UOPXIQSA7 
ESOF UOPXIQSAKOD247 
LSOF UOPXIQSAKPD2347 
 
Table (2.4): The chemicals used in the different media. Each chemical was given a 
letter code as described in table (2.2) and (2.3).  
 
 
DEPC-H2O: 
0.1% (v/v) diethyl procarbonate in mili-Q water. Mixed overnight then 
autoclaved for 30 min at 121˚C. 
 
50xTAE: 
242g Tris base with 571µl Glacial acetic acid and 100µl 0.5M EDTA 
(pH=8.0), make up to 1 L with DEPC H2O. 
 
Dissociation media: 
HSOF-CA, 3mg/ml BSA, 0.02% EDTA and 5µg/ml cytoclasin B (CB) 
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Substrates: 
Collagen: homemade collagen from rat tail, one part of collagen into five parts 
of distilled water. 
Collagen (2): sigma collagen type I from rat tail (3.85 mg/ml). Product 
number: C3867 
Gelatin: 0.1% gelatin (Sigma). 
Poly-L-lysine: Sigma (0.01%). Product noumber: P4707 
Fibronictin: human Fibronectin from BD Biosciences (Cat number 354008) 
1mg lyophilized. 
Laminin: (Invitrogen) Cat. number 23017-015, Lot. number 771124.mouse 
laminin from BD Biosciences (Cat. number 354232). 
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substrate Stock per 96-plate time temperature post coating supplier cat-no 
fibronectin 1 mg/ml 
100 ul stock + 4900 ul PBS --> 5 ml 
working >45 min RT 
remove fluid, air-
dry SIGMA F1141 
collagen I 
~25 mg/ml 
(=2.5%) 
100 ul stock + 4900 ul PBS--> 5 ml 
working 
>hours-
o/n 
RT/37C or 2-8C 
(o/n) 
remove fluid, air-
dry SIGMA C3867 
gelatin 1 mg/ml (0.1%) 5 ml stock/working 
>hours-
o/n 
RT/37C or 2-8C 
(o/n) 
remove fluid, air-
dry  SIGMA   
g/c (1:2) as above 1.7 ml gelatin + 3.4 ml collagen working 
>hours-
o/n 
RT/37C or 2-8C 
(o/n) 
remove fluid, air-
dry as above as above 
poly-L-
lysine 
0.1 mg/ml 
(0.01%) 
1000 ul stock + 4000 ul PBS--> 5 ml 
working >1h  RT wash PBS, air-dry SIGMA P4707 
laminin  1 mg/ml 
50 μl stock+ 450 μl PBS-->0.5 ml 
working >1h  RT wash PBS, air-dry Invitrogen 
23017-
015 
 
Table (2.5): Summary of the substrates used for coating, their concentration, coating method and their supplier. 
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Chapter Three  
Results 
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3.1 IVF development 
3.1.1: Introduction 
To obtain bovine outgrowths, first bovine embryos were produced by the standard 
IVP system. The resulting embryos were graded on day seven based on their stage of 
development and morphology as described in section 2. Embryos were given a grade 
1, 2 or 3, depending on their quality with those graded 1 suggested to be of the best 
quality.  The grading was recorded and development was determined and the cleavage 
rate at day one was recorded. The table below gives a summary of the total number of 
embryos used, their cleavage rate and blastocyst number (B) with the different grades. 
Embryos were cultured for a certain period of time depending on the experimental 
plan. There were a number of factors that affected the cleavage rate and the grade of 
embryo obtained, including the quality of the starting materials, the season in which 
the oocytes were obtained and technical factors. With the blastocysts graded 1 to 3 at 
day seven the cleavage rate was 25.0% and with blastocysts graded 1 to 2 it was 
12.7%. The average cleavage rate in all the experiments, including all embryos 
whether they remained in culture until day seven or not, was 55.0%. 
 
Figure (3.1): Outline of different developmental stage experiments and medium used for IVP 
embryos. Treatments ESOF: from day one to five, LSOF: from day five to seven, 2i or ESC 
media: from day 7.     
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Table (3.1): Embryo development in IVP.  The cleavage efficiency of the embryos is recorded.  The first line represents runs that produced 
embryos for 8-cell, 16-cell and morula experiments and the second line represents runs used for ICM experiments. The results describe a 
summary of the average number of ovaries used, the number of oocytes obtained, the total number of embryos, the cleavage rate and the 
percentage of morulae, the number of blastocysts at each of the different grades. All percentage values were calculated based on the number of 
each category related to the initial number of embryos used. nIVM is the number of oocytes matured, nIVF is the number of embryos used, 
nIVC is the number of embryos cultured, TMI-3 is the number of morula obtained, B1-3and B1-2 are the number of blastocysts graded 1-3 and 
1-2 respectively. 
 
 
n. 
no. 
ovari
es 
nIV
M 
oocyte 
recove
ry nIVF 
nIV
C 
>1-
cell 
% 
cleave
d (± 
SD) 
TM  
1-3 
%TM
1-3   (± 
SD)  B1-3 
%B1-
3 (± 
SD) 
B1-
2 
%B1-
2 (± 
SD) 
%B1-
3/ 
cleav
ed 
% B1-
2/B1-3 
(± SD) 
52 1714 10517 6.14 10122 9777 5410 
55.0% 
±20.0
% - - - - - - - - 
27 676 3735 5.53 3635 3557 1503 
42.0% 
±20.0
% 139 
3.9% 
±4.1% 889 
25.0
% 
±17.3
% 453 
12.7
% 
±8.7
% 59.0% 
51.0% 
±26.5
% 
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Figure (3.2): The percentage of embryos cleaved. The percentage was calculated based on the 
number of embryos cleaved at day one relative to the initial number of oocytes obtained.  The 
number of embryos used in each run varied from 70to 410 with a mean value of 200.  
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Figure (3.3): The percentage of Grade 1-3 blastocyst formation (blue) and percentage of 
Grade 1-2 blastocyst formation in the treatments that used day 7 embryos. The percentage 
was calculated based on the number of blastocysts relative to the initial number of embryos 
used. The number of embryos used in each run varied from 70 to 320 with a mean value of 
176.
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3.2 Developmental stage 
3.2.1. The effects of the stage of development on attachment 
3.2.2 Introduction 
Embryos at different stages of development were used to examine the affect of 
developmental stage on attachment in a number of different substrates. ICM or 64cell, 
16cell or 8cell, dissociated embryos were placed in pre-coated wells to analyse the 
stage of development associated with the highest plating efficiency.  
 
3.2.3 ICM culture 
ICM was isolated from day 7 embryos by immunosurgery. Isolated ICMs from grade 
1 and 2 embryos were plated on pre-coated 4-well plates with the different substrates; 
gelatin, collagen, laminin and poly-L-lysine. The purpose of the experiment was to 
determine the plating efficiency of the ICM relative to that found for other stages of 
development.  Plating efficiency was examined in the different extra cellular matrixes. 
The results are shown in (table 3.2) ICM cells plated on the different substrates 
attached to the surface, but with varying efficiency. Overall ICM attachment 
efficiency was (59%) 19/32.  
 
stage No.well 
culture 
vessel 
Average plating 
efficiency %  ±SD 
ICM 2 4-wellplate 58% (13/48) ±32.76% 
 
Table (3.2): ICM plating efficiency in the different substrates. The plating efficiency was 
calculated based on the number of outgrowths produced relative to the initial number of wells 
used. 
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Figure (3.4): The average plating efficiency of ICM on the different substrates; gelatin, 
collagen, laminin and poly-L-lysine. The plating efficiency was calculated based on the 
number of outgrowths produced relative to the initial number of wells used. 
 
3.2.4 Morulae culture 
Dissociated blastomeres derived from day 5 embryos were placed in pre-coated 4-well 
plates. Plates were coated with the different substrates; gelatin, collagen, laminin, and 
poly-L-lysine. Attachment was recorded on day 2 post plating. Also, the medium was 
changed on day 2 post plating from LSOF to N2B27. Also two inhibitors CHAIR and 
PD032 were added to the medium at this time to inhibit differentiation, starting from 
4-6-2010. The average efficiency of attachment in the different substrates was (32%) 
22/68.   
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stage 
culture 
vessel 
plating 
efficiency 
±SD 
day 5 
4 well 
plate 
31.00% 
(22/68) 
±32.46% 
 
Table (3.3): The average plating efficiency of dissociated morulae (day5) in the different 
substrates; gelatin, collagen, laminin and poly-L-lysine. The average was calculated based on 
the average of plating efficiency of each substrate, and the plating efficiency was calculated 
based on the number of outgrowths relative to the initial number of wells used for each 
substrate. 
 
 
Figure (3.5): The average plating efficiency of dissociated morulae in the different substrates; 
gelatin, collagen, laminin and poly-L-lysine. The average was calculated based on the 
average of plating efficiency of each substrate. 
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3.2.5 16-cell culture 
Dissociated blastomeres derived from day 3 embryos were placed on 96-well 
plates, as described in section (2). Dissociation media was used for blastomere 
separation to reduce pipetting the embryos. Either one or twenty blastomeres 
were placed in each well along with wells containing zona free blastomeres 
from non dissociated embryos. The medium was changed on day 6 post plating 
from ESOF to N2B27. Attachment was recorded on day 11 post plating and 
outgrowth production was recorded on day 20.The average of 16-cell 
attachment was (21%) 61/288. There was a significant different between (ZF 
not dis.) and 1 and 20 blastomeres plating efficiency (p < 0.05). 
blastomeres/well culture vessels 
%plating 
efficiency 
± SD 
1b 
96 well plate flat 
bottom 
7% 
(6/72) 
±9.19% 
20b 
96 well plate flat 
bottom 
11% 
(10/72) 
±14.85% 
ZF not dis (16) 
96 well plate flat 
bottom 
54% 
(41/72) 
±11.31* 
 
Table (3.4): The average plating efficiency results of 1blastomere, 20 blastomeres and 
zona free non dissociated embryos derived from day 3 (16-cell) embryos were plated 
in 96well flat bottom plates. Blastomeres were plated in pre-coated wells with gelatin 
and collagen, and on wells without any coating. Plating efficiency was calculated 
based on the number of attachments relative to the initial number of wells used for 
each treatment. * indicates significant results. 
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Figure (3.6): The average plating efficiency of 1blastomere, 20 blastomeres and zona 
free non dissociated embryos derived from 16-cell embryos. Plating efficiency was 
calculated based on the number of attachments relative to the initial number of wells 
used for each treatment. * indicates significant results. 
 
3.2.6 8-cell culture  
3.2.6.1 Introduction 
Dissociated blastomeres from 8 cell stage embryos plated in pre-coated 96 well 
plates, displayed fluid accumulation during the first 1-2 days. Dissociated 
plated blastomeres increased in size during this period. Adhesion to the pre-
coated culture plate was noticed from day4 in culture. On day 7, complete 
adhesion was recorded and the medium was changed. However, in some cases 
blastomeres did not attach to the surface, but were free floating in the medium. 
Further development or cleavage was associated with the blastomeres that did 
not adhere to the surface. In some cases, floating blastomeres formed 
blastocysts or vesicles.  
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3.2.6.2 Plating efficiency of 8-cell dissociated blastomeres 
Blastomeres derived from day 2 dissociated embryos were plated in pre-coated 
96-well plates. Different substrates were used to examine blastomere 
attachment including; gelatin, collagen, laminin, fibrinectin and poly-L-lysine. 
For each substrate different numbers of blastomeres were placed in the plate, 
starting from 1 single blastomere to about 20. In this set of experiments, two 
types of 96-well plates were used; plates with flat bottom wells and plates with 
conical bottom wells. The results shown in Figure 3.6 suggest that plating 
efficiencies increased with an increase in the number of blastomeres added to 
each well over the range of between 1 and 20 blastomeres per well.  Overall the 
attachment efficiency in all the different treatments was (28%) 250/899.  A 
Fisher test was carried out on this data which revealed that 20 blastomeres 
attachment was significant to the other blastomere number. 
Stage blastomeres/well %plating efficiency ± SD 
8-c (D2 pm) 1b 4% (12/288) ±6.52%  
8-c (D2 pm) 2b 0% (0/48) ±0% 
8-c (D2 pm) 4b 8%  (4/48) ±22.19% 
8-c (D2 pm) 8b 11% (11/96) ±25.52% 
8-c (D2 pm) 16b 38% (9/24) ±41.08% 
8-c (D2 pm) 20 65% (194/299) ±39.19% * 
8-c (D2 pm) ZF not dis 38% (18/48) ±36.98% 
 
Table (3.5): The average plating efficiency of different blastomere number derived 
from 8-cell embryos, in 96-well plates. The plating efficiency was calculated based on 
the number of attachments to the initial number of wells in each treatment. 
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Figure (3.7): The average plating efficiency of different number of blastomeres 
(1blastomer, 2blastomeres, 4 blastomeres, 8 blastomeres, 16 blastomeres, 20 
blastomeres, zona free not dissociated embryos and zona intact embryos) derived 
from dissociated day2 embryos. Plating efficiency was calculated based on the 
number of attachment to the initial number of wells used. * indicates significant 
results. 
 
 
 
 
 
 
 
*
0%
20%
40%
60%
80%
100%
P
la
ti
n
g
 e
ff
ic
ie
n
cy
 %
Blastomeres number
1b
2b
4b
8b
16b
20
ZF not dis
 75 
 
3.2.7: The effects of the stage of development on plating efficiency: 
The results above suggest that the developmental stage has an effect on plating 
efficiency.  ICM were associated with the best plating efficiency (58%) 19/32. 
Dissociated morula was the next with (32%) 22/68. Then, were 8-cell embryos 
with (28%) 250/899. 16-cell embryos were associated with the lowest plating 
efficiency with (21%) 61/288. This result is depicted in Figure (3.7). A 
statistical analysis carried out on this data (Fisher test), which revealed that 
data for ICM plating efficiency was significant to the other developmental 
stages (P < 0.05).   
 
 
 
Figure (3.8): The average plating efficiency of embryos from different stages of 
development; ICM, dissociated morulae, 16-cell and 8-cell. The plating efficiency 
was calculated based on the number of wells in which ICM or blastomeres attached 
relative to the initial number of wells used. 
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3.3 The correlation between the number of blastomeres plated and 
attachment 
3.3.1 Introduction 
Blastomeres from 8-cell and 16-cell embryos were plated as described in 
section 2. The number of blastomeres plated varied as described below. The 
purpose of plating different numbers of blastomeres was to investigate if there 
is a correlation between the number of blastomeres plated and the plating 
efficiency.     
 
3.3.2 16-cell embryo results  
As depicted in table (3.4) above, plating zona free non dissociated 16-cells 
embryos had the highest plating efficiency (54%) 41/72whereas When 1 
blastomere and 20 blastomeres were added the plating efficiencies were (7%) 
6/72 and (11%) 10/72 respectively.  This result is shown in Figure (3.8). A 
fisher test statistical analysis was carried out on this data, which revealed that 
plating efficiency of ZF non dis. was significantly different to 1 and 20 
blastomeres (P < 0.05).  
 
 
 77 
 
 
Figure (3.9): The plating efficiency of different numbers of blastomeres derived from 
day3 embryos. 1b; 1 blastomere, 20 b; 20 blastomeres, ZF; zona free not dissociated. 
The plating efficiency was calculated based on the number of wells in which embryos 
attached relative to the number of wells used. * indicates significant results. 
 
3.3.3 8-cell embryo results 
As depicted in Figure (3.9) the larger the number of blastomeres plated the 
better were the attachment results obtained, regardless of the substrate used. 
The addition of 1 blastomere per well resulted in 4% attachment 12/288. 
However, the addition of 2 blastomeres per well did not result in attachment of 
any embryos in experiments using 96 well plates (0%) 0/48. But, the addition 
of 4,8,16 and 20 blastomeres resulted in attachment and outgrowth, to variable 
extents. The loading of 4 blastomeres per well resulted in (8%) attachment 4/48 
and the loading of 8 blastomeres per well resulted in (11.5%) 11/96. The 
loading of 16 and 20 blastomeres per well  resulted in the highest levels of  
attachment with (38%) 9/24 and (65%) 194/299 respectively The use of zona 
free non dissociated 8-cell embryos and embryos resulted in attachment values 
of (38%) 18/48. A Fisher test was carried out on this data, which revealed that 
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20 blastomeres attachment efficiency was significantly higher than the other 
blastomere numbers used in the experiment (P < 0.05).  
 
 
 
Figure (3.10): The plating efficiency using different numbers of blastomeres 
(1blastomere, 2blastomeres, 4 blastomeres, 8 blastomeres, 16 blastomeres, 20 
blastomeres, zona free non dissociated embryos) derived from 8-cell embryos. Plating 
efficiency was calculated based on the number of wells in which embryos attached 
relative to the number of wells used. * indicates significant results. 
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3.4 Attachment in the different substrates 
3.4.1 Introduction 
In all the different treatments, plates were coated with different selected 
substrates as described in section (2). ICM, dissociated morula, 16-cell 
embryos and 8-cell embryos were analysed and selected. In addition, good 
quality embryos with an appropriate stage of development were further selected 
for better results. For ICM experiments, immunosurgery was done to isolate the 
ICM from the TE, as described in section 2. For the other experiments, 
blastomeres were dissociated and loaded into the plates as described in section 
(2).The overall objective of these experiments was to determine the best 
substrate for attachment. These experiments were repeated a number of times, 
in which five different substrates were used including gelatin, laminin, 
collagen, poly-L-lysine and a mixture of gelatin and collagen. The attachment 
of bovine blastomeres in the various substrates was significantly different as 
shown in the results below. 
 
3.4.2 ICM attachment in the different substrates 
Four different substrates were used for ICM attachment including; collagen, 
gelatin, laminin and poly-L-lysine. 4-well plates were coated as described in 
section 2. ICM was isolated by immunosurgery. As depicted in table (3.6) 
below gelatin and collagen had similar attachment efficiencies (75%) 6/8. 
Laminin had a lower efficiency of attachment with (50%) 4/8 and poly-L-
lysine was the lowest with (38%) 3/8.  
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stage no./well substarte 
culture 
vessel 
no. 
Plated 
Average of plating 
efficiency ± SD 
ICM 8 laminin 
4-well 
plate 4 50%  ± 40.82% 
ICM 8 collagen 4-wll plate 6 75%  ± 28.87% 
ICM 8 gelatin 4-wll plate 6 75%  ± 28.87% 
ICM 8 poly-L-lysine 4-wll plate 3 37.50%  ± 25% 
 
Table (3.6): The average ICM plating efficiency in the different substrates; collagen, gelatin, 
laminin and poly-L-lysine. The plating efficiency was calculated based on the number of 
wells in which embryos attached relative to the initial number of wells used. 
 
Figure (3.11): The average plating efficiency of ICM in the different substrates; collagen, 
gelatin, laminin and poly-L-lysine. The average plating efficiency was calculated based on 
the average number of wells in which embryos attached to the initial number of wells used. 
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3.4.3 Attachment of dissociated morula in the different substrates 
Dissociated morulae were plated on the different substrates; collagen, gelatin, laminin 
and poly-L-lysine in order to find out if there a substrate that promote attachment. As 
depicted in figure 3.11 below, gelatin had the best attachment results (50%) 8/16, and 
then was collagen (38%) 6/16. Laminin and poly-L-lysine had lower plating efficiency 
with (31%) 5/16 and (18%) 3/16 respectively.  
 
 
 
Figure (3.12): The average of plating efficiency of dissociated morulae in the different 
substrates; collagen, gelatin, laminin and poly-L-lysine; no: no coating was used. The average 
plating efficiency was calculated based on the average number of wells in which embryos 
attached to the initial number of wells used. 
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3.4.4 Attachment of 16-cell in the different substrates 
As depicted in figure 3.12 below, 16-cell treatments had slightly similar attachment in 
collagen (28%) 29/96 and gelatin with (25%) 26/96. However, without any coating 
(6%) 6/96 embryos were still able to attach.  
 
 
Figure (3.13): The average of plating efficiency of 16-cell different treatments in collagen, 
gelatin and no coating. The average plating efficiency was calculated based on the average 
number of wells in which embryos attached to the initial number of wells used. 
 
 
3.4.5 8-cell attachment in the different substrates 
The different treatments of 8-cell were plated on the different substrates; collagen, 
gelatin, gelatin/collagen, laminin and poly-L-lysine. The purpose of the experiments 
was to examine the plating efficiency in the different substrates and to find out the 
substrates that promote attachment. Attachment was scored on day 7 from plating and 
outgrowth production was scored on day 11 or 12. Media was changed every 3 to 4 
days in sterile conditions. Experiment results as shown in figure 3.13 indicated that 
overall gelatin was the best substrate to promote attachment and outgrowth production 
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in all the different blastomeres number 144/298 (58%), then laminin 21/76 (28%), 
collagen 31/183 (17%), and poly-L-lysine was 18/131 (14%). The worst attachment 
was associated with fibronectin and gelatin/collagen with 4% 2/48 and 3% 2/72 
respectively. These results were obtained based on the total number of blastomeres 
attached from the initial number of wells used.  A Fisher test was carried out on this 
data, which revealed that the attachment efficiency was significantly higher in gelatin 
than the other substrates (P < 0.05).   
 
 
 
Figure (3.14): The average of plating efficiency of 8-cell in the different substrates; collagen, 
fibronectin, gelatin, gelatin/collagen, laminin and poly-L-lysine. The average plating 
efficiency was calculated based on the average number of wells in which embryos attached to 
the initial number of wells used. * indicates significant results. 
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3.5 The effects of the different substrates on cell proliferation 
The objective of this experiment was to determine if the various substrates 
affected cell proliferation. Outgrowths after 20 to 21 days in culture were 
passaged enzymatically and the sells produced were counted as previously 
described in section (2). The number of cells counted on the different substrates 
was variable. Outgrowths from gelatin coated wells had more cells than the 
other substrates. The average cell number on gelatin was 8,290, while 2500 
were obtained on collagen, 4080 were obtained on poly-L-lysine and 4640 
were obtained on laminin.  A two tale t-test was carried out on this data, which 
revealed that gelatin significantly better for cell proliferation than the other 
substrates (P < 0.05).   
 
 
stage 
embryos/ 
well  
no. cells 
plated 
(estimate) Substrate 
days 
post-
plating 
Average number 
of cells ±SD 
8-cell 3 24 gelatin 20 8.29E+03 ±2289 * 
8-cell 3 24 laminin 20 4.64E+03 ±1574 
8-cell 3 24 poly-L-lysin 20 4.08E+03 ±2515 
8-cell 3 24 collagen 20 2.50E+03 ±500 
 
Table (3.7): The average cell number in outgrowths derived from the different 
substrates; gelatin, collagen, poly-L-lysine and laminin. The number of cells was 
calculated based on the total number of cells counted from each outgrowth using the 
haemocytometer. * indicates significant results.
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Figure (3.15): The affects of the different substrates on cell proliferation. Outgrowths 
were in culture for 19-21 days. The results present the average of the total number of 
cells counted from each outgrowth using the haemocytometer. 
 
3.6 Dissociated 8-cell culture in tissue culture plates 
3.6.1 Introduction 
Although the previous set of experiments using 96 well plates were successful 
in terms of outgrowth production, it was difficult to obtain outgrowth from 
small numbers of blastomeres such as when one or two blastomeres were 
plated. Therefore, using dimples as micro-wells was an appropriate suggestion 
to examine the possibility of obtaining outgrowths from 2 blastomeres as a 
start. The production and coating of the dimples was described in section (2). 
In these experiments only gelatin, which was the substrate associated with the 
best outgrowth results, was used.  
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3.6.2 Dissociated 8-cell culture in tissue culture plates 
The results of the experiments, summarised in Table 3.8 below indicated the 
possibility of obtaining outgrowths from 2 blastomeres, despite the low 
proportion of outgrowths obtained. Overall, comparison between the two sets 
of experiments showed that blastomere culture in 96 well plates and in tissue 
culture plates, produced similar results. Using a larger number of dissociated 
blastomeres in dimples resulted in better attachment and outgrowth production 
using twenty blastomeres in one dimple resulted in (79%) 22/28 of outgrowths, 
which was higher than the percentage obtained in 96 well plates (65%) 194/299 
using this number of blastomeres. Using eight dissociated blastomeres in 
dimples resulted in (36%) 35/96 of outgrowth production, which was also 
higher than the results obtained from deriving outgrowths in 96 well plates 
(11.5%) 11/96. Using four dissociated blastomeres in dimples resulted in (10%) 
22/216, which was also higher than the results obtained from 96-well plates 
(8%) 4/48.  However, two dissociated blastomeres plated in dimples resulted in 
(2%) of outgrowth production 9/412, which is low, but still better than the (0%) 
0/48 that was obtained from placing 2 blastomeres in 96 well plates. The 
plating efficiency was obtained based on the total number of wells in which 
blastomeres attached relative to the initial number of wells used.  A Fisher test 
was carried out on this data, which revealed that 20 blastomeres had 
significantly better attachment efficiency than the other blastomere numbers 
used in the experiment (P < 0.05).   
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stage b./well Average plating efficiency ± 
8-cell 2b 2% (9/412) ±2% 
8-cell 4b 
10% 
(22/216) ±3% 
8-cell 8b 36% (35/96) ±17% 
8-cell 20b 79% (22/28) ±17% * 
 
Table (3.8): The efficiency of attachment of dissociated 8-cell (day 2) embryos plated 
on gelatin pre coated dimples in tissue culture plates. The percentage was calculated 
based on the total number of wells in which blastomeres attached from the initial 
number of wells used. * indicates significant results. 
 
 
 
 
 88 
 
 
Figure (3.16): The average attachment associated with different blastomere numbers 
in outgrowths derived from dissociated day 2 blastomeres plated on gelatin coated 
dimples. The average plating efficiency was calculated based on the average number 
of wells in which embryos attached to the initial number of wells used.* indicates 
significant result.
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(a) 
 
(b) 
 
(c) 
 
Figure (3.17): Examples of outgrowths plated in dimples coated with gelatin in a 
tissue culture plate, images were taken on day 21 post plating.  
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3.7 Passaging bovine outgrowths: 
3.7.1 Introduction: 
When outgrowths filled the wells containing them, they needed to be passaged. 
Outgrowths were passaged by transferring them from the initial well to another 
bigger well or to a number of wells. Outgrowths were first passaged 
mechanically and then enzymatically. Mechanical passaging involved cutting 
the outgrowths using needles and enzymatic passaging involved the use of a 
number of different enzymes to separate the outgrowths from the substrates. 
The two techniques have different efficiencies and success rates. The 
enzymatic and mechanical passaging methods were described in section 2.   
 
3.7.2 Mechanical passaging: 
Between 86% and 88% of the outgrowths passaged mechanically reattached. 
Mechanical passaging was performed as described in section (2). The 
outgrowths derived from dissociated blastomeres were mechanically passaged 
when the cells filled the wells that contained them. It was necessary to change 
the media continually in order to maintain the supplements for the outgrowths 
to be maintained in culture. Mechanical passaging was highly successful in 
comparison to the enzymatic passaging.   
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no. passaged no. Reattached plating efficiency 
15 13 87% 
22 19 86% 
24 21 88% 
14 12 86% 
 
Table (3.9): Re-attachment efficiency of outgrowths passaged mechanically.  
Outgrowths re-attached on gelatin pre-coated 96 well plates. Plating efficiency was 
calculated based on the total number of outgrowths re-attached relative to the number 
of initial outgrowths passaged. 
 
3.7.2 Enzymatic passaging: 
As enzymatic passaging is more convenient and results in the better 
maintenance of a normal karyotype, the outgrowths were processed 
enzymatically when they filled the wells that contained them. Different 
enzymes were used to passage outgrowths derived from dissociated 
blastomeres. The outgrowths were enzymatically processed after at least one 
treatment of mechanical passaging. The enzymatic passaging method was 
described in section (2). Nine outgrowths were passaged using Trypsin, 10 
using accutase and 9 using dispase. The enzymatic processing was used to lift 
and detach the outgrowths from the substrate. Although outgrowths were lifted, 
when they were replated in new gelatin coated wells, they did not attach on 
most occasions. In a few cases they attached (5/29) (17%), but they developed 
a different morphology to the undifferentiated outgrowths. Of the five 
outgrowths that reattached three were treated with dispase, and one was treated 
with accutase and one was treated with trypsin.  
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stage culture vessel 
enzyme 
used 
Average 
plating 
efficiency 
±SD 
day 2 
96 well plate flat 
bottom Trypsin  
11% (1/9) 
±33.33% 
day 2 
96 well plate flat 
bottom Accutase 
10%(1/10) 
±31.62% 
day 2 
96 well plate flat 
bottom dispase 
33% (3/9) 
±50% 
 
Table (3.10). Re-attachment efficiency post enzymatic passaging. Enzymes used for 
passaging were trypsin, accutase and dispase. Outgrowths were derived from day two 
dissociated blastomeres plated on pre-coated gelatin dimples. Plating efficiency was 
calculated based on the number of outgrowths re-attached relative to the initial 
number of outgrowths passaged. 
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Figure (3.18): Re-attachment efficiency post enzymatic passaging. Enzymes used for 
passaging were trypsin, accutase and dispase. Outgrowths were derived from day 
dissociated blastomeres plated on pre-coated gelatin dimples. Plating efficiency was 
calculated based on the number of wells in which embryos attached to the initial 
number of wells used. 
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                       (a)                                                        (b) 
 
  
                         (c)                                                           (d) 
Figure (3.19): Examples of outgrowths plated on gelatin after enzymatic passaging 
using trypsin (2.5mg/ml).  
 
3.8 cDNA results 
3.8.1 cDNA samples    
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16 stored outgrowths were used to isolate RNA as described in section 
(2).Total RNA was extracted from bovine outgrowths and reverse transcribed 
into cDNA. mRNA was converted to cDNA in all the samples as described in 
section (2). cDNA samples were amplified by PCR and the PCR amplicons 
were resolved using agarose gel electrophoresis as described in section (2). 
Outgrowths were derived from dissociated day 2 embryos as described in 
section (2). Those outgrowths were grown in 96 well plates coated with gelatin, 
gelatin/collagen (2:1) and collagen as described in table (3.12). The number of 
blastomeres plated in each outgrowth is presented in table (3.12). The 
production of a PCR amplicon using gene specific primers was used to 
determine which of the selected genes were expressed in those outgrowths, and 
if there was a correlation between the substrates used for coating, the number 
of blastomeres plated and the genes expressed. Bovine mRNA sequences were 
obtained from AgResearch-bovine database and primers were designed by 
invitrogen. 
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primer 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 P H20 
SOX2 no no no no no no no no no no no no no no no no yes no 
DPPA3 no no yes no no yes yes yes no yes no yes yes no no yes yes no 
SALL4 yes no  yes yes yes yes yes yes no yes yes no yes yes ND yes yes no 
NANOG no no no ND no no no yes yes no no yes ND ND ND no yes no 
OCT4 no no no no yes no yes yes no no yes no yes no no no yes no 
KLF4 yes no yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes no 
FGF5 no no no no no no no no no no no no no No no no yes no 
LEFTY no ND yes no no no ND yes no yes yes yes no No ND no yes no 
CDX2 no no no yes no yes ND no ND yes yes yes yes yes no yes yes no 
β- 
ACTIN yes weak yes yes yes yes yes yes yes yes yes yes yes yes yes yes yes weak 
 
Table (3.11): Summary of results of testing the expression of the 10 genes in 16 samples derived from bovine outgrowths obtained from 
dissociated day 2 embryos in tissue culture plates, (no): no cDNA amplified ,no expression, (yes): cDNA amplified,  positive gene expression 
(ND): not determined, (P) positive control using genomic DNA sample from foetal liver tissue, H2O negative control. 
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sample 
no. substrate 
blastomere 
no. 
1 gelatin 24b 
2 gelatin 24b 
3 gelatin 24b 
4 gelatin 24b 
5 gelatin 8b 
6 collagen 24b 
7 gel/col 24b 
8 gel/col 16b 
9 gelatin 24b 
10 gelatin 24b 
11 gelatin 24b 
12 gelatin 24b 
13 gelatin 24b 
14 gelatin 24b 
15 gelatin 24b 
16 gelatin 24b 
 
Table (3.12): The 16 samples used for gene expression analysis, the substrates they 
were plated on and the initial number of blastomeres used to derive outgrowths. 
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Representative gels results are shown below: 
In figures (3.19, 3.20, 3.21, 3.22, 3.23, 3.24 and 3.25) the gel results testing the 
expression of the Sox2, Nanog, Oct4, Dppa3, Sall4, Fgf5, Cdx2, Lefty, Klf4 
and β-actin genes are shown. 
 
 
          
β-Actin (a) and SOX2 (b) gene expression 
Figure (3.20):  Gene expression of β-ACTIN and SOX2 in sixteen bovine outgrowths. 
Total RNA was extracted from bovine outgrowths and reverse transcribed into cDNA. 
The cDNA was then subjected to PCR analysis for gene expression of β-ACTIN and 
SOX2. Amplified DNA was resolved by agarose gel electrophoresis to detect the 
expression of the selected genes. The RNA was isolated from outgrowths derived 
from dissociated day 2 embryos grown on pre-coated plates as described in Table 
(3.11). The positive control (+) contained genomic DNA from foetal liver tissue and 
the negative control (H2O) contained water. A further control labelled (-) contained 
one blastocyst in error. 
β-actin: 
The results above indicated that β-actin was expressed in all the samples expect 
number 2, which had a weak expression. The expression in H2O was similar to 
the expression in sample (2) which was negative to all primers (no DNA).  
Sox2: 
The results above suggest that Sox2 was not expressed in any of the outgrowths 
detected. 
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DPPA3 (a), FGF5 (b) and SALL4 (c) gene expression 
 
Figure (3.21): (16) bovine outgrowths gene expression of DPPA3, FGF5 and SALL4. 
Total RNA was extracted from bovine outgrowths and reverse transcribed into cDNA. 
The cDNA was then subjected to PCR analysis for gene expression of DPPA3, FGF5 
and SALL4. Amplified DNA was resolved by agarose gel electrophoresis to detect 
the expression of the selected genes. The RNA was isolated from outgrowths derived 
from dissociated day 2 embryos grown on pre-coated plates as described in Table 
(3.11). The positive control (+) contained genomic DNA from foetal liver tissue and 
the negative control and the water (H2O).  
 
Dppa3: 
The results above indicated that dppa3 was expressed in samples 3, 6, 7, 8, 10, 
12, 13, 16.  
 
FGF5: 
The results above indicated that all the 16 samples did not express fgf5.  
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Sall4: 
The results above indicated that sall4 was expressed in samples 1, 3, 4, 5, 6, 7, 
8, 10, 11, 13, 14, 16.  
 
(a) 
 
(b) 
 
(c) 
 
Figure (3.22): (16) cDNA samples produced using primers specific for the Oct4 gene. 
Total RNA was extracted from bovine outgrowths and reverse transcribed into cDNA. 
The cDNA was then subjected to PCR analysis for gene expression of Oct4. 
Amplified DNA was resolved by agarose gel electrophoresis to detect the expression 
of the selected genes. The RNA was isolated from outgrowths derived from 
dissociated day 2 embryos grown on pre-coated plates as described in Table (3.11). 
The positive control (+) contained genomic DNA from foetal liver tissue and the 
negative control and the water sample (H2O).  
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Oct4: 
The results above indicated that oct4 was expressed in the samples 5, 7, 8, 11, 
13. 
 
(a) 
 
 
(b) 
 
Figure (3.23): (16) cDNA samples produced using primers specific for the Klf4 gene. 
Total RNA was extracted from bovine outgrowths and reverse transcribed into cDNA. 
The cDNA was then subjected to PCR analysis for gene expression of Klf4. 
Amplified DNA was resolved by agarose gel electrophoresis to detect the expression 
of the selected genes. The RNA was isolated from outgrowths derived from 
dissociated day 2 embryos grown on pre-coated plates as described in Table (3.11). 
The positive control (+) contained genomic DNA from foetal liver tissue and the 
negative control and the water sample (H2O).  
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Klf4: 
The results above indicated that klf4 was expressed in all the 16 samples.  
 
 
(a) 
 
(b) 
 
Figure (3.24): (16) cDNA samples produced using primers specific for the Cdx2 gene. 
Total RNA was extracted from bovine outgrowths and reverse transcribed into cDNA. 
The cDNA was then subjected to PCR analysis for gene expression of Cdx2. 
Amplified DNA was resolved by agarose gel electrophoresis to detect the expression 
of the selected genes. The RNA was isolated from outgrowths derived from 
dissociated day 2 embryos grown on pre-coated plates as described in Table (3.11). 
The positive control (+) contained genomic DNA from foetal liver tissue and the 
negative control and the water sample (H2O).  
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Cdx2: 
The results above indicated that cdx2 primer was expressed in the samples: 4, 
6, 10, 11, 12, 13, 14, 16.  
 
 
(a) 
 
(b) 
 
Figure (3.25): (16) cDNA samples produced using primers specific for the LEFTY 
gene. Total RNA was extracted from bovine outgrowths and reverse transcribed into 
cDNA. The cDNA was then subjected to PCR analysis for gene expression of Lefty. 
Amplified DNA was resolved by agarose gel electrophoresis to detect the expression 
of the selected genes. The RNA was isolated from outgrowths derived from 
dissociated day 2 embryos grown on pre-coated plates as described in Table (3.12). 
The positive control (+) contained genomic DNA from foetal liver tissue and the 
negative control and the water sample (H2O).  
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LEFTY: 
The results above indicated that lefty was expressed in the samples: 3, 8, 10, 
11, 12. 
               
 
(a) 
 
(b) 
 
Figure (3.26): (16) cDNA samples produced using primers specific for the NANOG 
gene. Total RNA was extracted from bovine outgrowths and reverse transcribed into 
cDNA. The cDNA was then subjected to PCR analysis for gene expression of 
NANOG. Amplified DNA was resolved by agarose gel electrophoresis to detect the 
expression of the selected genes. The RNA was isolated from outgrowths derived 
from dissociated day 2 embryos grown on pre-coated plates as described in Table 
(3.11). The positive control (+) contained genomic DNA from foetal liver tissue and 
the negative control and the water sample (H2O).  
   
NANOG: 
The results above indicated that NANOG was expressed in the samples: 8, 9, 
12. 
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3.9 Karyotyping: 
Karyotyping of cells in the outgrowths from dissociated blastomeres plated in 
dimples was carried out after the cells had been mechanically passaged and 
replated in a (48) well plate. Because of the small size of the wells, 5 wells with 
outgrowths were pooled to obtain the cells used for karyotyping as described in 
table (3.13). Karyotyping was done as described in section (2). The 
karyotyping was processed to determine if those outgrowths had a normal 
bovine chromosome number (60 chromosomes) and normal appearance. 
However, the majority of the images taken indicated an abnormal karyotype 
with varying numbers of chromosomes detected and abnormal chromosome 
appearance.   
 
Date of plating stage of embryo b.no Medium Time in culture 
3/9/2010 8 cell 8b standard ES medium 34 days 
3/9/2010 8cell 8b standard ES medium 34 days 
3/9/2010 8 cell 4b standard ES medium 34 days 
8/9/2010 8 cell 2b standard ES medium 30 days 
8/9/2010 8 cell 8b standard ES medium 30 days 
  
Table (3.13): Description of the five wells containing outgrowths that were pooled to produce 
the cell sample used for karyotyping, and the time they were in culture prior the karyotyping. 
8b; outgrowth derived from 8 dissociated blastomeres, 4b; outgrowth derived from 4 
dissociated blastomeres, 2b; outgrowth derived from 2 dissociated blastomeres.  
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Image 
chromosomes 
no. 
1 53 
2 58 
3 53 
4 57 
5 58 
6 26 
7 56 
9 59 
12 60 
13 54 
20 62 
22 16 
26 57 
31 56 
33 59 
  
Table (3.14): The number of chromosomes counted in cells derived from the pooled 
outgrowths described above. The outgrowths were derived from dissociated day 2 
embryos plated on pre-coated dimples in tissue culture plates. 
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(a)                                                                         (c) 
  
(b)                                                                         (d)   
 
Figure (3.27):  Four representative images of metaphase spreads of bovine outgrowths 
derived from day 2 dissociated blastomeres plated on pre-coated dimples in tissue 
culture plates. Outgrowths were passaged mechanically and re-plated on gelatin pre-
coated 48 well plates. Outgrowths were in culture for 31-34 days prior karyotyping 
and they were passaged three times. Image (a), (b) and (c) represent abnormal 
karyotypes of 53, 59 and 26 chromosomes respectively. Image d represents an 
abnormal karyotype of 60 chromosomes that have unusual sex chromosome 
morphology. 
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3.10  The affects of 2i media on outgrowths maintenance 
Bovine outgrowths derived from different developmental stages were cultured 
initially in 2i media. However, outgrowths were not maintained in 2i media, 
and many died prior the first passage, 22/31 (79%). Therefore, bovine 
outgrowths were culture in ESC media, in which cells were maintained and 
proliferated for longer time with medium regular changing. Outgrowths that 
maintained in culture up to the first passage were more than in 2i media 27/27 
(100%). A t-test was carried out on these results which revealed that ESC 
media was significantly better in bovine outgrowths maintenance than 2i media 
(P < 0.05). 
   
no. 
outgrowths 
in 2i media 
no. at 
passage 
1 % 
no. 
outgrowths 
in ESC 
media 
no. at 
passage 
1 % 
31 9 22.03% 27 27 
100% 
*  
 
Table (3.15): comparison between outgrowths cultured in 2i or ESC media. 
Outgrowths were in culture up to the first passage, and percentage was calculated 
based on the number of outgrowths at the first passage relative to the initial 
outgrowths number. * indicates significant results. 
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Figure (3.28): The percentage of outgrowths cultured in 2i or ESC media up to the first 
passage. The percentage was calculated based on the number of number of wells in which 
embryos attached to the initial number of wells used.  
  
 
3.11 The affects of 96-well plates (conical bottom) on cell attachment 
96-well flat bottom plates were used initially to derive bovine outgrowths. 
However, poor attachment results were associated with those plates 22/ 108 
(20.37%), therefore, they were replaced with the conical bottom ones. The use 
of conical bottom plates resulted in better attachment 156/182 (85.71%). A 
Fisher test was carried out on this data, which revealed that 96-well conical 
bottom plates had significantly better attachment efficiency than the flat bottom 
ones (P < 0.05).   
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96-well 
plates 
type no. wells 
no. 
outgrowths 
plating 
efficiency 
± SD 
Flat 
bottom 108 22 
20.37% ± 
31.19% 
Conical 
bottom 182 156 
85.71% ± 
28.27% * 
 
Table (3.16): Plating efficiency using 96-well plates (flat and conical bottom). Data 
was obtained from 8,16 and 20 blastomeres derived from day 2 and 3 embryos, plated 
in gelatin. The percentage was calculated based on the number of attachment relative 
to the initial number of wells used. * indicates that the result was significant.  
 
 
 
Figure (3.28): Comparison between 96-well flat bottom and conical bottom plates. 
The average plating efficiency was calculated based on the average number of wells 
in which embryos attached to the initial number of wells used. * indicates significant 
results. 
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Chapter Four 
Discussion 
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4.1 The effects of the stage of development on attachment 
In these experiments, embryos at different stages of development were used to 
examine their attachment efficiency. It is important to investigate the stage 
associated with the optimal embryonic development and high ESC derivation rate. 
Based on parameters such as morphological appearance and size of the resulting 
outgrowth, results of the experiments demonstrated that bovine embryos at 
different stages of development including; day 2, 3, 5, 7 embryos were capable of 
forming expanded outgrowths under the appropriate culture conditions. Starting 
materials were plated into pre-coated wells and cultured in hypoxic conditions 
using the appropriate medium to support bovine outgrowth.  
First, a comparison of the attachment results of the different developmental stages 
indicates that overall, ICM attachment was significantly higher than the other 
developmental stages. Day 2, 3, 5 and 7embryos were used, for day 2, 3 and 5 
blastomeres were dissociated then plated on the different substrates, whereas ICM 
cells were isolated by immunosurgery and then plated. ICM experiments were 
repeated 8 times, however, technical problems and issues associated with the 
complements led to the recording of only 2 experiments. ICM plating efficiency in 
all the substrates was (59%) 19/32. 
Dissociated morulae experiments were repeated 8 times as well. Attachment was 
recorded in 22 out of 68 (32%).  However, using the same stage of development, 
bES-like cells have been derived with higher efficiency rates (60-70%) 
(Strelchenko, Verlinsky et al. 2004).  
For pre-compacting stages, day 2 and 3 embryos were examined and different 
treatments within each stage were applied. In blastomeres derived from 16-cell 
embryos, four different groups of starting materials were used; 1 blastomere, 20 
blastomeres and zona free not dissociated embryos. Overall, attachment efficiency 
in all these treatments was (21%) 61/288. 8-cell stage experiments were the largest 
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group in terms of the number of times they were repeated (899). In those 
experiments successful attachment was recorded in 250 cases and the overall 
plating efficiency was 28%. This set of experiments had 8 different groups of 
starting materials to investigate the effects of blastomere number on the plating 
efficiency within each group. 
Concerns have been raised about the ability of earl stage embryos and dissociated 
blastomeres to form animals. However, researchers have successfully obtained 
ESCs from early developmental stage embryos. In human, offspring have been 
produced from dissociated blastomeres derived from 4-cell stage embryos (Geens, 
Mateizel et al. 2009). In addition, in bovine all four blastomeres derived from 4-
cell stage embryos developed into live offspring (Johnson, Loskutoff et al. 1995). 
HESC lines have been obtained from 2 out of 16 (12.5%) blastomeres derived 
from 4-cell stage human embryos, which indicated that, at least one out of the 4 
cells in the 4-cell stage human embryo is pluripotent. In addition, HESC lines have 
been derived from single dissociated 8-cell stage human embryos (Klimanskaya, 
Chung et al. 2007) with a 2% success rate.  (Chung, Klimanskaya et al. 2008) have 
improved the success rate to 20% by the use of a co-culture system with the parent 
embryos and laminin as an extra cellular matrix to promote adhesion to the surface 
(Chung, Klimanskaya et al. 2008). 
In mouse (Geens, Mateizel et al. 2009) reported that offspring can be obtained 
from dissociated blastomeres derived from 2-cell stage embryos but they cannot 
be obtained from embryos at further stages of development (Geens, Mateizel et al. 
2009). However, ESC lines have been produced from single dissociated 
blastomeres derived from 4- and 8- cell stage mouse embryos (Lorthongpanich, 
Yang et al. 2008). Despite the low success rate of ESCs derived from dissociated 
blastomeres, this system can be useful in reproduction technologies like PGD 
without interfering with embryo development (Chung, Klimanskaya et al. 2006). 
In addition, ESCs derived from pre-compacting embryos can contribute not only 
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to embryonic tissues, but also, to placental tissues (Mitalipova, Beyhan et al. 
2001). 
In 16-cell experiments, zona free non-dissociated embryos had a higher 
attachment rate (21%) than 20 dissociated blastomeres 11%. The lower plating 
efficiency may be related to the dissociation method that may affect blastomere 
competence. However, in experiments using 8-cell stage embryos, when 20 
blastomeres were plated the highest plating efficiency 65% (194/299) was 
obtained. The next most efficient used zona free non-dissociated embryos and 16 
blastomeres 38% (18/48) and (9/24) respectively. In 8-cell stage experiments, 
there was a clear positive correlation between the number of blastomeres plated 
and the attachment efficiency, which has been reported in previous studies (Vajta, 
Peura et al. 2000).  
From these experiments using embryos at different stages of development; day 2, 
3, 5 and 7, ICM cells had significantly the highest attachment efficiency. Day 2 
and 5 experiments had nearly a similar attachment efficiency and lastly were 
blastomeres derived from 16-cell stage embryos. This was the overall attachment 
efficiency in the four groups; ICM, morula, 16- and 8-cells, without taking in 
account the different treatments in 16- and 8-cells embryos in which different 
groups with varying number of blastomeres were plated. 
ESC lines have been produced from isolated ICM cells (Thomson, Itskovitz-Eldor 
et al. 1998), morulae (Strelchenko, Verlinsky et al. 2004), single blastomeres of 8-
cell stage embryos (Chung, Klimanskaya et al. 2008) and 4-cell stage dissociated 
blastomeres (Geens, Mateizel et al. 2009). Bovine offspring can be obtained from 
dissociated 4-cell embryos (Johnson, Loskutoff et al. 1995). In addition, bES-like 
cells have been derived from day 7-9 blastocysts (Muñoz, Díez et al. 2008), day 
12-14 embryos (GjÃ¸rret and Maddox-Hyttel 2004) and from zygotes and early 
cleavage embryos (Mitalipova, Beyhan et al. 2001). (Muñoz, Díez et al. 2008) 
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reported that the stage of development did not influence the effectiveness in 
establishing bES like cells (Muñoz, Díez et al. 2008). However, another study 
reported that day (8) hatched blastocysts produced more epiblast colonies than day 
9 blastocysts (Talbot, Powell et al. 1995). Different views about the best 
developmental stage make it complicated to determine the appropriate stage to 
derive bovine colonies. In addition, bovine embryos have a long pre-implantation 
period compared to mouse and human. Blastocyst forms at day 7 post-fertilization, 
and then it increases in size especially the endoderm and trophectoderm. At day 12 
bovine embryos still express Oct-4, which indicates the presence of pluripotent 
cells, however, cells derived from day 12 embryos were not self renewable(Gjorret 
and Maddox-Hyttel 2004). Therefore, it is unclear which stage of development 
would be better to derive bES-like cells (Gjorret and Maddox-Hyttel 2004). 
 Human embryos at the 4-cell stage differentially express Oct4 to direct cells 
either to the ICM or the TE (Deb, Sivaguru et al. 2006). In addition, Cdx2, which 
is a trophoblast specific gene, is expressed in late 2-cell stage mouse embryos 
(Hansis, Gifo et al. 2000). In human embryos genome activation occurs between 
the 4- and 8-cell stages and maternal effects are reduced significantly in the 8-cell 
stage embryos (Wong, Loewke et al. 2010). (Galan, Montaner et al. 2010) 
reported that blastomeres fate is not fixed until the 32-cell stage embryos however. 
(Muñoz, Díez et al. 2008) reported that the outer cells in compacting embryos lose 
their pluripotency even before the differentiation to ICM or TE. In bovine day 7 
embryos, the most favoured stage used to derive bES-like cells, and in which ICM 
is isolated, it has been reported that ICM cells are not equally pluripotent (Oback 
2008).   
Second, there was a correlation between the number of blastomeres plated and the 
attachment efficiency. (Mitalipova, Beyhan et al. 2001) had reported that the 
efficiency of plating group of blastomeres was higher than blastomeres from 
single 2-cell embryos (Mitalipova, Beyhan et al. 2001) . In addition, (Tagawa, 
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Matoba et al. 2008) had better developmental potential from 4 blastomeres derived 
from 8-cell embryos than from single blastomers derived from 2-cell embryos 
(Tagawa, Matoba et al. 2008). In my experiments, when 1, 2, 4, 8, 16 and 20 
blastomeres derived from 8-cell stage plated, attachment efficiency had a positive 
correlation with larger blastomere number. When 1 and 2 blastomeres plated, 
attachment was hardly obtained, however, plating of larger numbers of 
blastomeres resulted in better attachment efficiency, which supports the previous 
observations.  
 
4.2 Attachment in the different substrates 
The investigation of attachment in the different substrates revealed that the starting 
materials were able to become attached to all the substrates. However, varying 
attachment efficiencies were associated with each substrate. One observation in 
the experiments was that plated blastomeres resulted in either fast attachment or 
delayed attachment. Fast attachment to the pre-coated surface was associated with 
gelatin as attachment occured within the first 3-4 days post plating, (before 
forming blastocysts). The second observation was associated with collagen, 
gelatin/collagen, laminin and poly-L-lysine in which attachment was delayed to 
the period post the formation of the blastocyct. Attachment of blastomeres to pre-
coated dishes was similar to the results obtained by (Wilton and Trounson 1989), 
who reported the attachment of mouse single blastomeres to the pre-coated tissue 
culture plates, which was contrast to the (Saito and Niemann 1991) observation 
who showed development in blastomeres on pre-coated dishes without attachment 
to the bottom of the plates. The different observations can be explained by the 
variation in interaction between dissociated blastomeres and the different extra 
cellular matrix molecules. Blastomeres surface receptors may have more affinity 
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for gelatin so they attach to it shortly post plating, whereas they have less affinity 
for the other substrates so they may attach, but after blastocysts formation.  
(Irina, Young et al. 2006) reported that, ESCs derived from dissociated 
blastomeres developed trophectoderm like cells. To overcome this problem they 
aimed to recreate the ICM niche to prevent the differentiation to trophectoderm 
cells by the use of laminin. They found 93% of the obtained colonies were like 
ICM cells. In addition, they examined a number of substrates and found that 
laminin is better than fibronectin in promoting ICM-like colonies, because it may 
have a role in directing blastomeres to differentiate into ICM colonies. In another 
study, mESCs were undifferentiated when cultured on type I, II collagen and poly-
D-lysine, whereas they differentiated when cultured on laminin or fibronectin 
(Hayashi, Furue et al. 2007). Ying, 2003 has reported that, mESCs proliferated 
with the preservation of  pluripotency when they cultured on gelatin (Ying, 
Nichols et al. 2003). (Hoffman and Carpenter 2005) used different extra cellular 
matrixes to examine their attachment efficiency. They reported that laminin, 
matrigel and fibronectin promote long term growth (Hoffman and Carpenter 
2005). A combination of fibronectin and collagen was also reported to promote 
attachment and proliferation (Lu, Hou et al. 2006). 
Fibronectin is the first substrate to appear during bovine embryogenesis, it appears 
during development at day 7 as it underlies the ICM (Maddox-Hyttel, Alexopoulos 
et al. 2003). In addition, fibronectin exists in day13 embryos between the 
hypoblast and trophoblast (Maddox-Hyttel, Alexopoulos et al. 2003).  Laminin 
and collagen IV also exist between the hypoblast and trophoblast (Maddox-Hyttel, 
Alexopoulos et al. 2003). Related to bovine embryogenesis, fibronectin, laminin 
and collagen were expected to support bES-like cells derivation and proliferation. 
In our laboratories laminin has been used for ICM attachment experiments. 
However, in my experiments, ICM attached better in gelatin and collagen 75%, 
while ICM plated in laminin had a 50% attachment efficiency. In 16-cell stage 
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experiments gelatin and collagen had no significant differences in attachment 
being of the order of 28% and 25% respectively. In 8-cell stage experiments, 
gelatin was significantly the substrate associated with the highest attachment 
efficiency and then laminin. This finding was not expected as most of the previous 
reports recommended different substrates except gelatin.  
 
4.3 The effect of the different substrates on cell proliferation  
The size of outgrowths that grew on pre-coated plates with the different substrates 
varied. The spread of outgrowths in wells was the highest in gelatin as the 
outgrowths filled the wells within the time outgrowths were in culture (19-20 
days). However, there was a concern that cells attached to the other substrates may 
be more condensed than the ones grown on gelatin. This concern was investigated 
by counting the number of cells grown on the different substrates. The results of 
counting confirmed that outgrowths attached to gelatin had significantly (P < 0.05) 
more cells than the other substrates; poly-L-lysine, laminin and collagen.  
To start proliferation certain signals are required for DNA replication (Lu, Hou et 
al. 2006). These signals are transmitted from the extracellular matrix to the 
nucleus, and proliferation factors act by the binding to receptors on the cell surface 
(Lu, Hou et al. 2006). Affinity to the extracellular matrix has important affects on 
attachment and then on proliferation (Lu, Hou et al. 2006). It has been reported 
that any laminin isoform supports hESCs adhesion and proliferation for a number 
of passages with the preservation of their pluripotency determined by the high 
avidity to integrin α6β1 which is expressed by hESCs (Miyazaki, Futaki et al. 
2008). Other studies have reported different ECM that support attachment and 
proliferation (Lu, Hou et al. 2006). 
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Growth 
Matrix (+) (++) (+++) (++++) (+++++) 
Fibronectin 
  
x X 
 Collagen 
 
x 
 
x 
 Laminin x 
    Matrigel         X 
 
Table (4.1): A summary of cell proliferation in different coating matrices (Lu, Hou et al. 
2006). 
 
 4.4 8 –cell culture in tissue culture dishes 
It has been reported that outgrowths from 2 cell embryos were obtained when the 
amount of medium used was reduced from 50µl to 5µl (Mitalipova, Beyhan et al. 
2001). In 96 well plates, outgrowths from 1 and 2 blastomeres were difficult to 
obtain. One possible reason for this was the ratio between the medium volume and 
the number of cells plated. In our group the standard culture system involves the 
culture of 10-15 embryos in 20µl drops until day 7 (blastocyst stage). The culture 
of a group of embryos in the same drop enhances their development because 
during early stage of development cell to cell communication is important for 
development and attachment (Nagao, Iijima et al. 2008).   
To culture individual or a small number of blastomeres, micro-wells or (well 
within a well) system is used. The micro-well system is often used to culture 
mammalian zygotes individually or in small groups to obtain genetically identical 
animals and to increase the number of offspring from valuable parents (Tagawa, 
Matoba et al. 2008). Experiments using the micro-well system demonstrated that 
there is a correlation between the amount of medium and blastomere number. To 
culture a small number of blastomeres the amount of medium needs to be reduced. 
Reduction of the amount of medium used in 96-well plates was not possible 
because this would have led to the evaporation of medium and consequently the 
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dessication of the blastomeres. Another option was to overlay small volume drops 
with mineral oil to prevent evaporation, however, this can cause the oil to mix 
with the medium and lead to negative affects on blastomere development. 96-well 
plates have the smallest volume of wells, therefore, no other plate option was 
available. Therefore, depressions in tissue culture plates were the solution in order 
to obtain wells with a smaller volume for blastomere culture. Groups with 
different numbers of depressions were made in tissue culture plates, coated and 
then covered with 20µl medium. In these experiments, outgrowths from 2 
dissociated blastomeres were obtained despite the low efficiency and attachment 
was faster than that found in 96-well plate experiments (4 and 7days) respectively. 
In addition, as found for experiments using dissociated blastomeres plated into 96-
well plates experiments, the number of blastomeres plated into dimples also has a 
positive correlation with the attachment efficiency, iso that 20 blastomeres had the 
highest attachment efficiency between the different group numbers plated in 
depressions. However, it was important to take care to make wells with clean 
edges to improve the attachment of blastomeres and the spread of outgrowths. 
In addition to the micro-well system, to derive blastomere derived ESCs, a co-
culture system was used in other studies to enhance the success of the method. 
Single blastomeres were not able to develop when they were plated into 20-100 µl 
drops of culture medium (Chung, Klimanskaya et al. 2006). In the co-culture 
system dissociated blastomeres are cultured with either the parent embryo, ESCs 
or other dissociated blastomeres (Klimanskaya, Chung et al. 2007). In a number of 
studies it has been reported that the co-culture system is even essential to derive 
blastomere derived ESCs (Chung, Klimanskaya et al. 2006), (Irina, Young et al. 
2006) and (Klimanskaya, Chung et al. 2007) with the aid of other factors 
including, the spatial orientation of blastomeres, the feeder layer, ESCs number 
and media components (Chung, Klimanskaya et al. 2006). However, it was not 
clear whether the success of this system was attributed to facilitating cell-cell 
 121 
 
signals or to substances secreted by ESCs (Chung, Klimanskaya et al. 2006). In 
addition, co-culture system may lead to the fusion of dissociated blastomeres ESC 
lines with ESCs or parent embryos used for the co-culture (Chung, Klimanskaya et 
al. 2006), which may cause contamination of the cell line produced.  
However, a co-culture system is not essential to derive bovine outgrowths in 
dimples (micro-wells). In my experiments attachment was achieved without the 
use of a co-culture system, which was reported to aid the attachment of small 
number of blastomeres (Klimanskaya, Chung et al. 2007). Also, (Tagawa, Matoba 
et al. 2008) has reported that a co-culture system was not essential to derive ESC 
from single dissociated blastomeres.  
 
4.5 Passaging bovine outgrowths  
In these experiments bovine outgrowths were not able to be passaged with 
enzymes. When outgrowths reached the appropriate size they were ready to be 
passaged to promote proliferation and to increase cell number. In my experiments 
enzymatic passaging was not successful in most cases. Discrenable outgrowths 
were obtained by day 11 from plating and wells were filled with cells on day 20-
21 from plating, so they needed to be passaged. Cells were passaged first 
mechanically at least once before the enzymatic passaging. However, when cells 
were passaged enzymatically they ceased togrow or differentiated. A number of 
enzymes were used in this study for enzymatic dissociation including; trypsin, 
accutase, collagenase and dispase to examine their ability to dissociate in bovine 
outgrowths, however, none of them resulted in attachment and proliferation. In 
one experiment out of 29 outgrowths only 5 (17%) reattached, but they 
differentiated (table 3.10). The method of cell passaging is important in order to 
maintain ESCs. To passage mouse ESCs, trypsin has been used successfully, but 
the use of trypsin in bovine can cause differentiation and loss of proliferation 
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(Strelchenko 1996). In addition, (Mitalipova, Beyhan et al. 2001) has reported that 
bES-like cells were sensitive to trypsin and other enzymes therefore it has been 
suggested that it is better to dissociate cells mechanically (Mitalipova, Beyhan et 
al. 2001).  However, (Gong, Roach et al. 2010) were able to passage bES-like cells 
by trypsin and trypLE is expressed without the loss of pluripotency. In another 
study, accutase which is a combination of a protease and collagenolytic enzymes 
was reported to be better than trypsin for enzymatic passaging (Nagaoka, Si-Tayeb 
et al. 2010). 
ESCs are diploid primary cells with self renewal ability; they are sensitive to the 
culture environment and dependent on cell to cell and extra cellular matrix 
interactions. (Gong, Roach et al. 2010) has reported the importance of using the 
mechanical method of passaging for the first three times to limit the total 
dissociation. Cell to cell signals are essential during the early developmental 
stages to maintain pluripotency. The number of bESCs increased during the three 
mechanical passages so the cell to cell signals are suggested to have improved. 
Therefore, it has been suggested that applying enzymatic passaging after a series 
of mechanical passaging  may not affect pluripotency (Gong, Roach et al. 2010). 
In addition, (Gong, Roach et al. 2010) have reported the positive effects of using  
knock out serum replacement (KSR) instead of FCS in bESCs culture media as it 
may contribute to an improvement in the results of enzymatic passaging. (Kim, 
Chu et al. 2008) also pointed the negative influence of FCS in mESCs. However, 
different bovine culture systems have been examined in order to produce bovine 
ESC lines, but no proliferating cell lines have been obtained (Muñoz, Díez et al. 
2008). 
Despite the negative effects of enzymatic passaging it is an important method in 
gene targeting, maintenance and banking of bES-like cells. In addition, enzymatic 
passaging is important in obtaining single cells in order to derive gene targeted 
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cell lines. In (Gong, Roach et al. 2010) study of bES-like cells, colonies were 
passaged enzymatically beyond the third passage using 0.05% trypsin-EDTA, 
TrypLE expression and liberase 0.15 units/ml. They found positive results with 
both trypsin and TrypLE expression, however, liberase which is a combination of 
collagenase and protease, induced differentiation of bES- like cells. The culture 
medium may be the answer to the difficulties associated with enzymatic 
passaging. The addition of some factors like rho-associated kinase (ROCK) 
signalling may reduce apoptosis caused by dissociation (Couture 2010). 
However, in my experiments mechanical passaging was highly efficient with 80-
85% success rate. Mechanical passage is often used in ESCs system to separate 
ESC colonies to clumps. Some described the mechanical dissociation as a tedious, 
inefficient and difficult process with limited reproducibility (Couture 2010). 
However, others describe it as a reliable method in order to maintain HESC 
pluripotency (Couture 2010). In my experiments mechanical dissociation was 
applied once before the enzymatic dissociation, which may be not enough to 
increase cell number and cell to facilitate cell signals.  
 
4.6 The effects of the culture medium on the development and maintenance of 
bovine outgrowths: 
The affects of the culture medium on the development and maintenance of 
outgrowths was addressed. Two culture media were used; N2B27 and ESC 
medium. Both media were capable of maintaining bovine outgrowths in culture. 
Our culture conditions were capable to establishing and maintaining bovine 
outgrowths, but only for few passages. Outgrowths were derived at a similar time 
post plating (day 11) in both media. However, ESC culture medium was superior 
to N2B27 culture medium especially in outgrowth maintenance. In a number of 
cases outgrowths cultured in N2B27 medium died within 4-5 weeks post plating 
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despite the initial attachment and outgrowth production. However, outgrowths 
cultured in ESC medium were maintained in culture for a longer time.  Some of 
the outgrowths were in culture for 100 days with continuous changing of the 
medium despite the low proliferating rate. However, the differences between the 
use of N2B27 medium and ESC medium could not be completely determined as 
the number of cells in outgrowths cultured in N2B27 was not counted. 
It could be that the addition of bovine LIF and the differentiation inhibitors can 
improve culture medium. Also, the addition of some factors like (ROCK) rho-
associated kinase signalling may reduce apoptosis caused by dissociation (Couture 
2010). In addition, (Gong, Roach et al. 2010) have reported the positive effects of 
using knock out serum replacement (KSR) instead of FCS in bESCs culture 
media. However, in another report, hESCs cultured in medium with serum 
replacement form differentiated cells in ESCs colonies (Lu, Hou et al. 2006). 
 
4.7 The effects of pronase and dissociation method on blastomere 
development and attachment 
In this study, pronase was used in all experiments to remove zona pellucida, and to 
act as a dissociation medium in order to separate blastomeres.  The use of pronase 
to remove the zona pellucida has been reported to have some effects on the 
development of dissociated blastomeres as reported in previous studies (Alfred, 
Meniono et al. 1983). The zona pellucida gives  mechanical protection around 
blastomeres and it has an important role in enhancing cleavage and development 
(Alfred, Meniono et al. 1983). However, in these experiments the removal of zona 
pellucida did not negatively influence blastomere development and attachment 
(Alfred, Meniono et al. 1983). 
In my experiments, embryos were exposed to pronase and the dissociation 
medium for a few minutes (2-5 min), and dissociated blastomeres were washed in 
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HSOF medium to remove any toxic substances. There was no clear negative 
effects associated with the use of pronase and the dissociation medium, which 
were used to manipulate embryos in all the different treatments, however, 
variation in attachment and cell number were related to stage of development, 
initial blastomere number plated and the substrate used. Attachment in some 
treatments was high such as 20 blastomere attachment on gelatin in conical wells 
(92%), which eliminated any negative effects of pronase and dissociation method 
on attachment. 
 
4.8 Gene expression 
Genes expressed in association with pluripotency are well established in human 
and mouse cells. Nanog, Oct-4 and Sox-2 are the major markers associated with 
pluripotency in human and mouse. In bovine, however, there are no specific 
markers associated with pluripotency. Nanog, which is a specific marker for ICM 
in human and mouse, is expressed by the ICM and the TE in bovine blastocysts. In 
addition, TE cells express OCT4, SOX2 and Nanog, (epiblast markers), and 
trophoblast specific genes (Cdx2) (Muñoz, Rodríguez et al. 2008). Therefore, 
these genes may not be associated with pluripotency. Pluripotency can be 
maintained by the balance of gene expression through the control of pluripotency 
networks. In the early stages of forming bovine outgrowths, TE cells are still 
expressing epiblast genes and at the same time trophoblast specific genes are 
expressed (Muñoz, Rodríguez et al. 2008), which may in part explain the slow 
differentiation of bovine outgrowths. More work has been suggested to be 
neseccary in order to identify the specific bovine pluripotency markers (Muñoz, 
Rodríguez et al. 2008). 
To examine gene expression in bovine outgrowths in my experiments, the 
expression of 10 different genes was investigated including, Nanog, Oct4, Sox2, 
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Klf4, Dppa3, Sall4, Fgf4, Lefty, Cdx2 and β-Actin. The outgrowths used to isolate 
cDNA were grown on different substrates, gelatin, collagen and gelatin/collagen 
mixture to further examination of substrates effects on pluripotency.  These genes 
represent ESCs or naive stem cells genes NANOG, OCT4, SOX2, DPPA3, 
SALL4 and KLF4, epiSCs genes LEFTY and FGF5, a trophectoderm gene CDX2 
and a loading control β-ACTIN. Some of the samples used for gene expression 
analysis showed expression for ESCs genes, epiblast genes and trophectoderm 
genes, because of the lack of uniformity. There was thousands of cells in each 
outgrowth expression of a certain gene did not mean that this gene was expressed 
in all the cell population because they were heterogeneous. The use of 2i media 
was to promote uniformity, however, the media did not enhance proliferation and 
cells maintenance. Therefore, ESC medium was used. More research on 2i 
medium is needed to find factors that support bES-like cells proliferation and 
maintenance.           
In addition, (Cauffman, De Rycke et al. 2009) reported that markers that define 
pluripotency in hESCs were unable to identify pluripotency in early 
developmental stages (pre-implantation embryos). More research is needed to 
identify gene expression patterns that associated with pluripotency in early stages 
of development. 
4.9 Karyotyping 
The karyotype of outgrowths obtained from dissociated blastomeres plated on pre-
coated wells was abnormal. Outgrowths were passaged mechanically twice post 
karyotyping and they remained in culture for 34 days. This period in culture is 
considered to be short in comparison to other studies. However, it was enough to 
cause chromosome abnormalities to be observed in all of the metaphase spreads. 
These chromosome abnormalities suggested that the outgrowths were either 
initially abnormal or that they had acquired an abnormal karyotype because of the 
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media or the derivation system. Previous studies have been reported abnormal 
ESCs (Mitalipova, Beyhan et al. 2001). Abnormalities can be caused by different 
HESC derivation systems or because of the culture system and can be seen to 
increase with the time outgrowths spent in culture (Närvä, Autio et al. 2010). A 
greater time in culture means more passages which may influence karyotyping. 
Immortal cells become aneuploid and polyploid when they are kept in culture for a 
long period of time and they develop an unstable karyotyping (Mitalipova, Beyhan 
et al. 2001). Outgrowths can have an abnormal karyotype because it was generated 
from embryos with an abnormal karyotype or their abnormal karyotype was 
acquired in culture (Moore 2006). In contrast, some studies in HESCs reported 
that chromosomally abnormal embryos can produce normal ESC lines by self 
correction. In addition, ESCs may have an impaired DNA repair system, so it does 
not initiate apoptosis in abnormal cells (Närvä, Autio et al. 2010). Also, because 
ESCs are cultured in hypoxic conditions, their mismatch repair system is down 
regulated (Närvä, Autio et al. 2010). 
 
4.10 Conclusion 
The results of the present study have suggested that bovine outgrowths can be 
obtained from different developmental stages including dissociated blastomeres 
derived from day 2 and 3 embryos. The use of different ECMs prevents 
contamination and promoted attachment and proliferation with variable rates, in 
which gelatin was the best substrate to promote attachment and proliferation in 
blastomeres derived from day 2 embryos. Gene expression in obtained outgrowths 
was did not show a uniform pattern, and markers were expressed in some of the 
outgrowths related to the lack of homogeneity. In addition, all metaphase spreads 
of outgrowths at passage three presented abnormal karyotype. 2i media was used 
to inhibit differentiation, however, it did not promote proliferation. In terms of 
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tissue culture plates, 96-well conical bottom plates were better than the flat bottom 
ones in promoting attachment.     
   
4.11 Future research: 
The establishment of bES-like cells would be useful to define gene expression 
during early bovine embryogenesis. However, it is important to find the 
appropriate culture conditions that would promote bES-like cell proliferation and 
stabilise their karyotype. The use of 2i media in deriving bES-like cells is useful in 
order to inhibit differentiation and to introduce uniformity into the cell population, 
but more research is needed to find out factors that inhibit cell death associated 
with 2i media and to promote cell proliferation. In addition, in bovine, the genetic 
background variability is high, therefore more work is needed to decrease this 
variability and to specify bovine pluripotency markers. In order to maintain 
outgrowth proliferation in culture, passaging is essential, therefore, improving the 
enzymatic passaging method is important to work on. Still, the optimal 
developmental stage with which to derive the naive state is unknown, therefore, 
further examination of different developmental stages is needed.    
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no. 
ovaries nIVM 
oocyte 
recovery IVF date sperm Trtmt nIVF nIVC 
>1-
cell 
% 
cleaved 
TM1-
3 
%TM1-
3 
B1-
3 
%B1-
3 
B1-
2 
%B1-
2 
%B1-
3/cleaved 
% B1-
2/B1-3 
20 130 6.5 12/11/2009 Dustin  SOP 110 67 21 31.3% 2 3.0% 2 3.0% 0 0.0% 9.5% 0.0% 
15 70 4.666667 18/11/2009 Dustin  SOP 70 70 22 31% 0 0.0% 12 17.1% 7 10.0% 54.5% 58.3% 
15 100 6.666667 25/11/2009 Dustin  SOP 100 94 0 0% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
10 60 6 2/11/2009 Dustin  SOP 60 60 28 47% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 180 6 26/01/2010 Dustin  B- culture 180 160 0 0% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 220 7.333333 27/01/2010 Dustin  B- culture 215 180 75 42% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 320 10.66667 3/2/2010 Dustin  B- culture 300 300 160 53% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 160 5.333333 4/2/2010 Dustin  B- culture 130 130 70 54% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 170 5.666667 9/2/2010 Dustin  ICMculture 170 160 35 22% 4 2.5% 21 13.1% 12 7.5% 60.0% 57.1% 
30 160 5.333333 10/2/2010 Dustin  ICMculture 160 160 42 26% 3 1.9% 27 16.9% 20 12.5% 64.3% 74.1% 
30 170 5.666667 16/02/2010 Dustin  ICMculture 170 170 31 18% 3 1.8% 19 11.2% 12 7.1% 61.3% 63.2% 
30 150 5 18/02/2010 Dustin  ICMculture 140 120 45 38% 6 5.0% 30 25.0% 18 15.0% 66.7% 60.0% 
30 150 5 23/02/2010 Dustin  ICMculture 145 140 48 34% 5 3.6% 32 22.9% 20 14.3% 66.7% 62.5% 
30 145 4.833333 24/02/2010 Dustin  ICMculture 145 145 52 36% 6 4.1% 35 24.1% 20 13.8% 67.3% 57.1% 
30 140 4.666667 2/3/2010 Dustin  ICMculture 140 145 41 28% 8 5.5% 18 12.4% 13 9.0% 43.9% 72.2% 
30 130 4.333333 4/3/2010 Dustin  ICMculture 130 130 57 44% 22 16.9% 21 16.2% 12 9.2% 36.8% 57.1% 
30 120 4 10/3/2010 Dustin  ICMculture 110 90 48 53% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 180 6 11/3/2010 Dustin  ICMculture 180 170 35 21% 0% 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
35 170 4.857143 16/3/2010 Dustin  ICMculture 160 150 64 43% 17 11.3% 33 22.0% 19 12.7% 51.6% 57.6% 
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35 180 5.142857 17/3/2010 Dustin  ICMculture 170 150 60 40% 6 4.0% 39 26.0% 9 6.0% 65.0% 23.1% 
30 180 6 18/3/2010 Dustin  ICMculture 180 160 67 42% 9 5.6% 40 25.0% 15 9.4% 59.7% 37.5% 
35 220 6.285714 24/3/2010 Dustin  ICMculture 220 220 132 60% 0 0.0% 132 60.0% 55 25.0% 100.0% 41.7% 
35 220 6.285714 25/3/2010 Dustin  ICMculture 220 216 130 60% 5 2.3% 124 57.4% 61 28.2% 95.4% 49.2% 
36 250 6.944444 8/4/2010 Dustin  ICMculture 240 235 144 61% 18 7.7% 92 39.1% 44 18.7% 63.9% 47.8% 
30 210 7 13/4/2010 Dustin  ICMculture 205 200 130 65% 2 1.0% 80 40.0% 37 18.5% 61.5% 46.3% 
30 170 5.666667 14/4/2010 Dustin  ICMculture 160 153 93 61% 3 2.0% 65 42.5% 43 28.1% 69.9% 66.2% 
60 320 5.333333 20/4/2010 Dustin  ICMculture 310 302 178 59% 20 6.6% 67 22.2% 36 11.9% 37.6% 53.7% 
32 250 7.8125 28/4/2010 Dustin  M culture 247 245 188 77% 100 40.8% 0 0.0% 0 0.0% 0.0% 0.0% 
30 210 7 29/4/2010 Dustin  M culture 205 202 161 85% 85 42.1% 0 0.0% 0 0.0% 0.0% 0.0% 
30 200 6.666667 3/5/2010 Dustin  M culture 200 190 149 78% 80 42.1% 0 0.0% 0 0.0% 0.0% 0.0% 
30 160 5.333333 4/5/2010 Dustin  M culture 150 150 99 66% 49 32.7% 0 0.0% 0 0.0% 0.0% 0.0% 
30 200 6.666667 12/5/2010 Dustin  M culture 190 190 130 68% 80 42.1% 0 0.0% 0 0.0% 0.0% 0.0% 
30 230 7.666667 13/5/2010 Dustin  B- culture 220 220 146 66% 65 29.5% 0 0.0% 0 0.0% 0.0% 0.0% 
30 170 5.666667 19/5/2010 Dustin  M culture 170 165 92 56% 67 40.6% 0 0.0% 0 0.0% 0.0% 0.0% 
30 260 8.666667 26/5/2010 Dustin  B- culture 250 250 145 58% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 300 10 29/5/2010 Dustin  M culture 290 290 170 59% 84 29.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 260 8.666667 1/6/2010 Dustin  B- culture 255 250 175 70% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 210 7 3/6/2010 Dustin  M culture 200 200 130 65% 50 25.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 150 5 8/6/2010 Dustin  B- culture 130 125 87 70% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
60 410 6.833333 14/6/2010 Dustin  B- culture 400 390 210 54% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
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Table (3.1): Summary of the number of ovaries used, number of oocytes obtained, treatments, total number of embryos, cleavage rate and the 
percentage of morulae and blastocysts produced with the different grades. The percentage calculated based on the number of each category 
related to the initial number of embryos.
37 190 5.135135 15/6/2010 Dustin  B- culture 180 165 95 58% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
33 190 5.757576 21/6/2010 Dustin  B- culture 180 175 105 60% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 210 7 22/6/2010 Dustin  B- culture 200 200 147 74% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
32 230 7.1875 28/6/2010 Dustin  B- culture 220 210 155 74% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 190 6.333333 7/7/2010 Dustin  B- culture 180 175 127 73% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
43 300 6.976744 3/8/2010 Dustin  B- culture 285 280 195 70% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
40 310 7.75 9/8/2010 Dustin  B- culture 290 285 210 74% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
37 230 6.216216 10/8/2010 Dustin  B- culture 220 215 150 70% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
34 147 4.323529 17/8/2010 Dustin  B- culture 145 140 94 67% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
40 145 3.625 25/8/2010 Dustin  B- culture 130 128 80 63% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
50 330 6.6 31/8/2010 Dustin  B- culture 320 320 180 56% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
40 150 3.75 1/9/2010 Dustin  B- culture 140 140 85 61% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
30 160 5.333333 9/6/2010 Dustin  B- culture 155 150 97 65% 0 0.0% 0 0.0% 0 0.0% 0.0% 0.0% 
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stage no./well Substarte culture vessel no. Plated plating efficiency 
ICM 2 laminin 4-wellplate 1 50% 
ICM 2 laminin 4-wellplate 0 0% 
ICM 2 collagen 4-wellplate 1 50% 
ICM 2 collagen 4-wellplate 1 50% 
ICM 2 gelatin 4-wellplate 2 100% 
ICM 2 gelatin 4-wellplate 1 50% 
ICM 2 poly-L-lysine 4-wellplate 1 50% 
ICM 2 poly-L-lysine 4-wellplate 1 50% 
ICM 2 laminin 4-wellplate 1 50% 
ICM 2 laminin 4-wellplate 2 100% 
ICM 2 collagen 4-wellplate 2 100% 
ICM 2 collagen 4-wellplate 2 100% 
ICM 2 gelatin 4-wellplate 1 50% 
ICM 2 gelatin 4-wellplate 2 100% 
ICM 2 poly-L-lysine 4-wellplate 0 0% 
ICM 2 poly-L-lysine 4-wellplate 1 50% 
 
Table (3.2): Summary of the results of ICM culture experiments in the different 
substrates. The plating efficiency was calculated based on the number of outgrowths 
produced relative to the initial number of wells used. 
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substrate no. of wells no. plated no. of outgrwoth pating efficiency 
gelatin 2 11 2 100.00% 
collagen 2 13 1 50.00% 
laminin 2 6 0 0.00% 
poly-L-lysine 2 7 1 50.00% 
no 1 0 0 0.00% 
gelatin 2 10 0 0.00% 
collagen 2 8 1 50.00% 
laminin 2 4 1 50.00% 
poly-L-lysine 2 2 0 0.00% 
no 1 0 0 0.00% 
gelatin 2 8 1 50.00% 
collagen 2 6 1 50.00% 
laminin 2 10 0 0.00% 
poly-L-lysine 2 2 0 0.00% 
no 1 0 0 0.00% 
gelatin 2 9 2 100.00% 
collagen 2 7 0 0.00% 
laminin 2 5 1 50.00% 
poly-L-lysine 2 3 0 0.00% 
no 1 0 0 0.00% 
gelatin 2 11 0 0.00% 
collagen 2 8 1 50.00% 
laminin 2 5 1 50.00% 
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poly-L-lysine 2 1 1 50.00% 
gelatin 2 9 1 50.00% 
collagen 2 6 1 50.00% 
laminin 2 8 1 50.00% 
poly-L-lysine 2 3 0 0.00% 
gelatin 2 7 0 0.00% 
collagen 2 9 0 0.00% 
laminin 2 7 1 50.00% 
poly-L-lysine 2 2 0 0.00% 
gelatin 2 7 2 100.00% 
collagen 2 6 1 50.00% 
laminin 2 0 0 0.00% 
poly-L-lysine 2 0 0 0.00% 
 
Table (3.3): Summary of the morulae dissociation experiments, with the substrates used, 
the number of attached morulae and the number of outgrowths produced. The number of 
attached blastomeres was estimated, and the plating efficiency was calculated based on 
the number of outgrowths resulted relative to the initial number of wells used for each 
substrate. 
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blastomeres/well N substrate culture vessels 
no 
plated 
(D11) 
%plating 
efficiency 
1 8 - 96 well plate flat bottom  0 0% 
1 8 collagen 96 well plate flat bottom  0 0% 
1 8 gelatin 96 well plate flat bottom  0 0% 
20+ 8 - 96 well plate flat bottom  0 0% 
20+ 8 collagen 96 well plate flat bottom  0 0% 
20+ 8 gelatin 96 well plate flat bottom  0 0% 
ZF not dis (16) 8 - 96 well plate flat bottom  2 25% 
ZF not dis (16) 8 gelatin 96 well plate flat bottom  2 25% 
ZF not dis (16) 8 collagen 96 well plate flat bottom  7 88% 
ZI (16) 8 - 96 well plate flat bottom  0 0% 
ZI (16) 8 collagen 96 well plate flat bottom  0 0% 
ZI (16) 8 gelatin 96 well plate flat bottom  0 0% 
1 8 - 96 well plate flat bottom  0 0% 
1 8 collagen 96 well plate flat bottom  1 13% 
1 8 gelatin 96 well plate flat bottom  2 25% 
1 8 - 96 well plate flat bottom  0 0% 
1 8 collagen 96 well plate flat bottom  1 13% 
1 8 gelatin 96 well plate flat bottom  2 25% 
20+ 8 - 96 well plate flat bottom  0 0% 
20+ 8 collagen 96 well plate flat bottom  2 25% 
20+ 8 gelatin 96 well plate flat bottom  3 38% 
20+ 8 - 96 well plate flat bottom  0 0% 
20+ 8 collagen 96 well plate flat bottom  2 25% 
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20+ 8 gelatin 96 well plate flat bottom  3 37% 
ZF not dis (16) 8 - 96 well plate flat bottom  1 13% 
ZF not dis (16) 8 collagen 96 well plate flat bottom  7 88% 
ZF not dis (16) 8 gelatin 96 well plate flat bottom  7 88% 
ZF not dis (16) 8 - 96 well plate flat bottom  1 13% 
ZF not dis (16) 8 gelatin 96 well plate flat bottom  7 87% 
ZF not dis (16) 8 collagen 96 well plate flat bottom  7 87% 
ZI (16) 8 gelatin 96 well plate flat bottom  0 0% 
ZI (16) 8 - 96 well plate flat bottom  1 13% 
ZI (16) 8 collagen 96 well plate flat bottom  1 13% 
ZI (16) 8 gelatin 96 well plate flat bottom  0 0% 
ZI (16) 8 collagen 96 well plate flat bottom  1 13% 
ZI (16) 8 - 96 well plate flat bottom  1 13% 
 
Table (3.4): Summary of the plating efficiency results from plating day 3 (16-cell) 
embryos on 96 flat bottom well plates. Different number of dissociated blastomeres was 
plated, 1blastomere; 20 blastomeres and zona free dissociated embry. Blastomeres were 
plated on pre-coated wells with gelatin and collagen, and on wells without coating. 
Plating efficiency was calculated based on the number of attachments related to the initial 
number of wells used for each treatment. 
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blastomeres/well n Substrate 
no 
plated 
(D11) 
%plating 
efficiency 
no 
outgrowth 
(D21) 
1 36 - 0 0% 0.00 
1 36 collagen 0 0% 0.00 
1 36 
gelatin/collagen 
(2:1) 0 0% 0.00 
1 36 fibronectin 2 6% 2.00 
1 36 poly-L-lysin 5 14% 4.00 
1 36 gelatin 2 6% 2.00 
8 4 - 0 0% 0.00 
8 4 collagen 0 0% 0.00 
8 4 fibronectin 0 0% 0.00 
8 4 gelatin 0 0% 0.00 
8 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
8 4 poly-L-lysin 0 0% 0.00 
ZF not dis (8) 4 - 0 0% 0.00 
ZF not dis (8) 4 fibronectin 0 0% 0.00 
ZF not dis (8) 4 gelatin 0 0% 0.00 
ZF not dis (8) 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
ZF not dis (8) 4 collagen 1 25% 1.00 
ZF not dis (8) 4 poly-L-lysin 2 50% 2.00 
ZI (8) 4 - 0 0% 0.00 
ZI (8) 4 collagen 0 0% 0.00 
ZI (8) 4 fibronectin 0 0% 0.00 
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ZI (8) 4 gelatin 0 0% 0.00 
ZI (8) 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
ZI (8) 4 poly-L-lysin 0 0% 0.00 
1 8 - 0 0% 0.00 
1 8 collagen 1 13% 1.00 
1 8 gelatin 2 25% 2.00 
20+ 8 - 0 0% 0.00 
20+ 8 collagen 2 25% 2.00 
20+ 8 gelatin 3 38% 3.00 
ZI (8) 8 - 1 13% 1.00 
ZI (8) 8 collagen 1 13% 1.00 
ZI (8) 8 gelatin 0 0% 0.00 
ZF not dis (8) 8 collagen 7 88% 7.00 
ZF not dis (8) 8 gelatin 7 88% 7.00 
ZF not dis (8) 8 - 1 13% 1.00 
20+ 25 gelatin 24 96% 14.00 
20+ 24 gelatin 21 88% 0.00 
20+ 17 gelatin 15 88% 0.00 
20+ 25 gelatin 22 88% 15.00 
20+ 20 gelatin 19 95% 13.00 
20+ 7 poly-L-lysin 1 14% 0.00 
20+ 7 laminin 2 29% 0.00 
20+ 7 collagen 5 71% 3.00 
20+ 7 gelatin 7 100% 4.00 
20+ 16 collagen 7 44% 2.00 
 xii 
 
20+ 16 poly-L-lysin 10 63% 5.00 
20+ 16 gelatin 14 88% 9.00 
20+ 16 laminin 14 88% 6.00 
1 4 collagen 0 0% 0.00 
1 4 gelatin 0 0% 0.00 
1 4 laminin 0 0% 0.00 
1 4 poly-L-lysin 0 0% 0.00 
2 4 collagen 0 0% 0.00 
2 4 gelatin 0 0% 0.00 
2 4 laminin 0 0% 0.00 
2 4 poly-L-lysin 0 0% 0.00 
4 4 collagen 0 0% 0.00 
4 4 gelatin 0 0% 0.00 
4 4 laminin 0 0% 0.00 
4 4 poly-L-lysin 0 0% 0.00 
8 4 collagen 0 0% 0.00 
8 4 gelatin 0 0% 0.00 
8 4 poly-L-lysin 0 0% 0.00 
20+ 4 laminin 0 0% 0.00 
20+ 4 poly-L-lysin 0 0% 0.00 
20+ 4 collagen 1 25% 1.00 
8 4 laminin 2 50% 2.00 
20+ 4 gelatin 4 100% 4.00 
1 4 collagen 0 0% 0.00 
1 4 gelatin 0 0% 0.00 
 xiii 
 
1 4 laminin 0 0% 0.00 
1 4 poly-L-lysin 0 0% 0.00 
2 4 collagen 0 0% 0.00 
2 4 gelatin 0 0% 0.00 
2 4 laminin 0 0% 0.00 
2 4 poly-L-lysin 0 0% 0.00 
4 4 collagen 0 0% 0.00 
4 4 laminin 0 0% 0.00 
4 4 poly-L-lysin 0 0% 0.00 
8 4 collagen 0 0% 0.00 
8 4 laminin 0 0% 0.00 
8 4 poly-L-lysin 0 0% 0.00 
20+ 4 collagen 0 0% 0.00 
20+ 4 poly-L-lysin 0 0% 0.00 
4 4 gelatin 1 25% 1.00 
8 4 gelatin 2 50% 2.00 
20+ 4 gelatin 3 75% 3.00 
20+ 4 laminin 3 75% 2.00 
1 4 collagen 0 0% 0.00 
1 4 gelatin 0 0% 0.00 
1 4 laminin 0 0% 0.00 
1 4 poly-L-lysin 0 0% 0.00 
2 4 collagen 0 0% 0.00 
2 4 gelatin 0 0% 0.00 
2 4 laminin 0 0% 0.00 
 xiv 
 
2 4 poly-L-lysin 0 0% 0.00 
4 4 collagen 0 0% 0.00 
4 4 laminin 0 0% 0.00 
4 4 poly-L-lysin 0 0% 0.00 
8 4 collagen 0 0% 0.00 
8 4 laminin 0 0% 0.00 
8 4 poly-L-lysin 0 0% 0.00 
20+ 4 laminin 0 0% 0.00 
20+ 4 poly-L-lysin 0 0% 0.00 
8 4 gelatin  2 50% 2.00 
4 4 gelatin 3 75% 3.00 
20+ 4 collagen 3 75% 3.00 
20+ 4 gelatin 4 100% 3.00 
8 4 collagen 0 0% 0.00 
8 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
16 4 collagen 1 25% 1.00 
16 4 
gelatin/collagen 
(2:1) 1 25% 1.00 
20+ 4 
gelatin/collagen 
(2:1) 1 25% 1.00 
20+ 4 collagen 2 50% 2.00 
8 4 gelatin  4 100% 4.00 
16 4 gelatin  4 100% 4.00 
20+ 4 gelatin 4 100% 4.00 
8 4 collagen 0 0% 0.00 
8 4 gelatin 1 25% 0.00 
 xv 
 
8 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
16 4 collagen 0 0% 0.00 
16 4 gelatin 3 75% 0.00 
16 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
20+ 4 collagen 0 0% 0.00 
20+ 4 gelatin 3 75% 0.00 
20+ 4 
gelatin/collagen 
(2:1) 0 0% 0.00 
 
Table (3.5): Summary of the plating efficiency of dissociated 8-cell embryos, in 96-well 
plates. The plating efficiency was calculated based on the number of attachments related 
the initial number of wells in each treatment. 
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